(+)-(S)-ar-turmerone affects binding ISO RGD:69168 6480464 ar-turmerone binds to PPARG protein CTD PMID:15713005 (+)-alpha-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 (+)-alpha-tocopherol increases expression ISO RGD:3371 6480464 alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:11752099 (+)-alpha-tocopherol increases expression ISO RGD:69168 6480464 alpha-Tocopherol results in increased expression of PPARG mRNA, alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 , PMID:28062356 (+)-alpha-tocopherol increases activity ISO RGD:69168 6480464 alpha-Tocopherol results in increased activity of PPARG protein CTD PMID:19083475 (+)-catechin multiple interactions ISO RGD:3371 6480464 Catechin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:23365609 (+)-schisandrin B multiple interactions ISO RGD:3371 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPARG mRNA] CTD PMID:31150632 (-)-citrinin decreases activity ISO RGD:69168 6480464 Citrinin results in decreased activity of PPARG protein CTD PMID:27481073 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:69168 6480464 epigallocatechin gallate results in decreased expression of PPARG mRNA CTD PMID:20706672 (25R)-cholest-5-ene-3beta,26-diol increases expression ISO RGD:3371 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA, 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosahexaenoic acid multiple interactions EXP 6480464 17-hydroxy-4 more ... CTD PMID:17056761 (R)-carnitine multiple interactions ISO RGD:3371 6480464 Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein] CTD PMID:30256492 (R)-carnitine increases expression ISO RGD:3371 6480464 Carnitine results in increased expression of PPARG protein CTD PMID:30256492 (R)-lipoic acid multiple interactions ISO RGD:3371 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 (R)-mevalonic acid multiple interactions ISO RGD:3371 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 (R)-noradrenaline increases expression ISO RGD:3371 6480464 Norepinephrine results in increased expression of PPARG mRNA CTD PMID:19109942 (S)-naringenin multiple interactions ISO RGD:3371 6480464 N-hydroxy-N'-4-butyl-2-methylphenylformamidine inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:29223569 , PMID:31063766 (S)-naringenin multiple interactions EXP 6480464 naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein] CTD PMID:31063766 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of PPARG mRNA CTD PMID:31622651 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of PPARG mRNA CTD PMID:26682919 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose multiple interactions EXP 6480464 beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA], beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein] CTD PMID:30721698 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of PPARG mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 1,3-thiazolidine-2,4-dione increases expression ISO RGD:3371 6480464 2, 4-thiazolidinedione results in increased expression of PPARG mRNA CTD PMID:20724125 1,3-thiazolidine-2,4-dione multiple interactions ISO RGD:69168 6480464 2, 4-thiazolidinedione binds to and results in increased activity of PPARG protein CTD PMID:15521013 1,3-thiazolidine-2,4-dione affects binding ISO RGD:69168 6480464 2, 4-thiazolidinedione binds to PPARG protein CTD PMID:15916743 1,4-bis(2-ethylhexyl) sulfosuccinate multiple interactions ISO RGD:69168 6480464 Dioctyl Sulfosuccinic Acid binds to and results in increased activity of PPARG protein CTD PMID:26135921 1,4-bis(2-ethylhexyl) sulfosuccinate increases activity EXP 6480464 Dioctyl Sulfosuccinic Acid results in increased activity of PPARG protein CTD PMID:26135921 1,4-phenylenediamine increases expression ISO RGD:69168 6480464 4-phenylenediamine results in increased expression of PPARG mRNA CTD PMID:16314067 1-naphthyl isothiocyanate decreases expression ISO RGD:3371 6480464 1-Naphthylisothiocyanate results in decreased expression of PPARG mRNA CTD PMID:30723492 13-HPODE increases expression ISO RGD:3371 6480464 13-hydroperoxy-9, 11-octadecadienoic acid results in increased expression of PPARG protein CTD PMID:22135674 14-Deoxy-11,12-didehydroandrographolide multiple interactions EXP 6480464 14-deoxy-11 more ... CTD PMID:30248417 15-acetyldeoxynivalenol decreases activity ISO RGD:69168 6480464 15-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:69168 6480464 15-deoxy-delta12 more ... CTD PMID:11030710 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity ISO RGD:69168 6480464 15-deoxy-delta12, 14-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15707588 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:69168 6480464 15-deoxy-delta12, 14-prostaglandin J2 results in decreased expression of PPARG protein CTD PMID:17341418 15-deoxy-Delta(12,14)-prostaglandin J2 affects expression ISO RGD:69168 6480464 15-deoxy-delta12, 14-prostaglandin J2 affects the expression of PPARG CTD PMID:15254749 15-deoxy-Delta(12,14)-prostaglandin J2 decreases response to substance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased susceptibility to 15-deoxy-delta12, 14-prostaglandin J2 CTD PMID:19922793 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:3371 6480464 15-deoxy-delta12 more ... CTD PMID:10662598 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity EXP 6480464 15-deoxy-delta12, 14-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15322177 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:3371 6480464 15-deoxy-delta12 more ... CTD PMID:15994020 , PMID:18278065 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 15-deoxy-delta12 more ... CTD PMID:12847270 , PMID:16324150 17alpha-ethynylestradiol multiple interactions EXP 6480464 ESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of PPARG mRNA] CTD PMID:29112739 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PPARG mRNA CTD PMID:29112739 17beta-estradiol multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]], [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA CTD PMID:19619570 , PMID:21734263 17beta-estradiol affects expression ISO RGD:3371 6480464 Estradiol affects the expression of PPARG mRNA, Estradiol affects the expression of PPARG protein CTD PMID:22389237 17beta-estradiol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 17beta-estradiol increases expression ISO RGD:69168 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:19619570 more ... 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:18359623 17beta-estradiol decreases expression ISO RGD:69168 6480464 Estradiol results in decreased expression of PPARG mRNA CTD PMID:21632903 more ... 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:69168 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA, Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:18801408 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of PPARG mRNA CTD PMID:16990341 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA, Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:12960001 1H-pyrazole increases expression EXP 6480464 pyrazole results in increased expression of PPARG mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 , PMID:31449830 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:31449830 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:29112739 , PMID:29523931 2,2',4,4'-Tetrabromodiphenyl ether increases activity ISO RGD:69168 6480464 2 more ... CTD PMID:26172262 , PMID:28282128 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:23398518 2,2',4,4'-Tetrabromodiphenyl ether decreases methylation EXP 6480464 2 more ... CTD PMID:24559133 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:24559133 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:69168 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,2'-Dihydroxy-4-methoxybenzophenone increases expression ISO RGD:69168 6480464 dioxybenzone results in increased expression of PPARG mRNA CTD PMID:32407875 2,2'-Dihydroxy-4-methoxybenzophenone affects binding ISO RGD:69168 6480464 dioxybenzone binds to PPARG protein CTD PMID:32407875 2,2'-Dihydroxy-4-methoxybenzophenone multiple interactions ISO RGD:69168 6480464 dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA], dioxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein] CTD PMID:32407875 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononanoic acid increases expression EXP 6480464 hexadecafluoro-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:18583369 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:24058054 , PMID:27713108 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69168 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA, Tetrachlorodibenzodioxin results in decreased expression of PPARG protein CTD PMID:12758056 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69168 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] more ... CTD PMID:12758056 more ... 2,4,6-tribromophenol affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4,6-trichlorophenol affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:3371 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA] more ... CTD PMID:16782535 more ... 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA CTD PMID:21829567 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:3371 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA, Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein CTD PMID:16782535 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases methylation EXP 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:69168 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:30903904 2,4-dinitrotoluene increases expression EXP 6480464 2, 4-dinitrotoluene results in increased expression of PPARG mRNA CTD PMID:24893713 2,4-dinitrotoluene increases activity EXP 6480464 2, 4-dinitrotoluene results in increased activity of PPARG protein CTD PMID:24893713 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of PPARG mRNA CTD PMID:19925653 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:69168 6480464 Butylated Hydroxytoluene inhibits the reaction [ironII-ascorbic acid complex results in decreased expression of PPARG mRNA] CTD PMID:17070507 2,6-diisopropylnaphthalene multiple interactions ISO RGD:69168 6480464 2, 6-diisopropylnaphthalene binds to and results in increased activity of PPARG protein CTD PMID:27633901 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 [lipopolysaccharide more ... CTD PMID:30236599 , PMID:30550845 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:3371 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression EXP 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 2-arachidonoylglycerol affects binding ISO RGD:69168 6480464 glyceryl 2-arachidonate metabolite binds to PPARG protein CTD PMID:21511917 2-arachidonoylglycerol multiple interactions EXP 6480464 glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein] more ... CTD PMID:26209559 2-arachidonoylglycerol multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA] CTD PMID:21511917 2-arachidonoylglycerol increases expression ISO RGD:69168 6480464 glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA CTD PMID:21511917 2-bromohexadecanoic acid increases expression ISO RGD:3371 6480464 2-bromopalmitate results in increased expression of PPARG protein CTD PMID:10650946 2-deoxy-D-glucose affects uptake EXP 6480464 PPARG protein affects the uptake of Deoxyglucose CTD PMID:18083318 2-deoxy-D-glucose increases uptake EXP 6480464 PPARG gene polymorphism results in increased uptake of Deoxyglucose CTD PMID:18083318 2-Ethylhexanoic acid increases expression ISO RGD:3371 6480464 2-ethylhexanoic acid results in increased expression of PPARG mRNA, 2-ethylhexanoic acid results in increased expression of PPARG protein CTD PMID:15647598 2-Ethylhexyl acrylate multiple interactions ISO RGD:69168 6480464 2-ethylhexyl acrylate binds to and results in increased activity of PPARG protein CTD PMID:27633901 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:3371 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 25-hydroxycholesterol multiple interactions ISO RGD:69168 6480464 [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA], [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol] CTD PMID:12595494 26-hydroxycholesterol increases expression ISO RGD:3371 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA, 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:3371 6480464 pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein] CTD PMID:16598202 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:3371 6480464 Puromycin Aminonucleoside results in increased expression of PPARG protein CTD PMID:16598202 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:69168 6480464 3 more ... CTD PMID:25304490 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:28973532 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:69168 6480464 2-methyl-2H-pyrazole-3-carboxylic acid 2-methyl-4-o-tolylazophenylamide inhibits the reaction [3 more ... CTD PMID:25304490 3,3',4,4'-tetrachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:30935970 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:69168 6480464 tetrabromobisphenol A binds to and results in increased activity of PPARG protein more ... CTD PMID:21561829 more ... 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:3371 6480464 tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:69168 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:32473317 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein], GW 1929 inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein] CTD PMID:24132472 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of PPARG protein CTD PMID:24132472 3,3',5,5'-tetrabromobisphenol A affects binding ISO RGD:69168 6480464 tetrabromobisphenol A binds to PPARG protein CTD PMID:25314719 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:25863188 , PMID:30496566 3,3',5,5'-tetrabromobisphenol A increases activity EXP 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:25777084 more ... 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:3371 6480464 tetrabromobisphenol A results in decreased expression of PPARG mRNA CTD PMID:26988606 3,3',5,5'-tetrabromobisphenol A increases activity ISO RGD:69168 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:24591153 more ... 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:3371 6480464 Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 3,4-Dimethylbenzaldehyde multiple interactions ISO RGD:69168 6480464 3, 4-dimethylbenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 3,5,6-trichloro-2-pyridinol multiple interactions EXP 6480464 3 more ... CTD PMID:32017950 3,5,6-trichloropyridine-2-one multiple interactions EXP 6480464 3 more ... CTD PMID:32017950 3,6-diaminoacridine multiple interactions ISO RGD:69168 6480464 Proflavine inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases expression ISO RGD:69168 6480464 MK-886 results in increased expression of PPARG mRNA CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid affects localization ISO RGD:69168 6480464 MK-886 affects the localization of PPARG protein CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:69168 6480464 [Indomethacin co-treated with MK-886] affects the localization of PPARG protein, Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein] CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases activity ISO RGD:69168 6480464 MK-886 results in increased activity of PPARG protein CTD PMID:15899809 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:69168 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] CTD PMID:16945329 3-acetyldeoxynivalenol decreases activity ISO RGD:69168 6480464 3-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 3-aminobenzamide increases activity ISO RGD:3371 6480464 3-aminobenzamide results in increased activity of PPARG protein CTD PMID:18815186 3-aminobenzamide multiple interactions ISO RGD:3371 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 3-aminobenzamide decreases ADP-ribosylation ISO RGD:3371 6480464 3-aminobenzamide results in decreased ADP-ribosylation of PPARG protein CTD PMID:18815186 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 +-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... 3-isobutyl-1-methyl-7H-xanthine increases expression ISO RGD:69168 6480464 1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA CTD PMID:22645054 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:3371 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA CTD PMID:21350315 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69168 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of PPARG mRNA more ... CTD PMID:19186324 more ... 3-phenylprop-2-enal decreases expression EXP 6480464 cinnamic aldehyde results in decreased expression of PPARG mRNA CTD PMID:21401097 4,4'-sulfonyldiphenol increases expression ISO RGD:69168 6480464 bis4-hydroxyphenylsulfone results in increased expression of PPARG mRNA CTD PMID:27003841 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis4-hydroxyphenylsulfone results in increased expression of PPARG mRNA CTD PMID:30951980 , PMID:30959087 4,4'-sulfonyldiphenol increases activity ISO RGD:69168 6480464 bis4-hydroxyphenylsulfone analog results in increased activity of PPARG protein, bis4-hydroxyphenylsulfone results in increased activity of PPARG protein CTD PMID:29331639 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69168 6480464 bis4-hydroxyphenylsulfone binds to and results in decreased activity of PPARG protein more ... CTD PMID:27633901 , PMID:30138673 4,4'-sulfonyldiphenol increases activity EXP 6480464 bis4-hydroxyphenylsulfone results in increased activity of PPARG protein CTD PMID:27273607 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bis4-hydroxyphenylsulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:27241191 more ... 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of PPARG protein CTD PMID:22200888 4-(ethoxymethylene)-2-phenyloxazol-5-one multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] CTD PMID:22200888 4-hydroxynon-2-enal decreases expression ISO RGD:69168 6480464 4-hydroxy-2-nonenal results in decreased expression of PPARG protein CTD PMID:27417252 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of PPARG mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases activity ISO RGD:69168 6480464 Fenretinide results in increased activity of PPARG protein CTD PMID:16274795 4-nonylphenol increases expression ISO RGD:3371 6480464 4-nonylphenol results in increased expression of PPARG mRNA CTD PMID:24388992 5-aza-2'-deoxycytidine affects expression ISO RGD:69168 6480464 Decitabine affects the expression of PPARG mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression ISO RGD:69168 6480464 Decitabine results in increased expression of PPARG mRNA CTD PMID:16763620 5-azacytidine decreases methylation EXP 6480464 Azacitidine results in decreased methylation of PPARG promoter CTD PMID:19589179 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of PPARG mRNA CTD PMID:19589179 5-fluorouracil decreases expression ISO RGD:69168 6480464 Fluorouracil results in decreased expression of PPARG protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:69168 6480464 PPARG protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-formyltetrahydrofolic acid multiple interactions ISO RGD:3371 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA, [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein CTD PMID:25187349 6-propyl-2-thiouracil decreases expression ISO RGD:3371 6480464 Propylthiouracil results in decreased expression of PPARG mRNA CTD PMID:24780913 8-(4-chlorophenylthio)-cGMP multiple interactions EXP 6480464 8-4-chlorophenylthioguanosine 3' more ... CTD PMID:20471953 8-(4-chlorophenylthio)-cGMP increases expression EXP 6480464 8-4-chlorophenylthiocyclic-3', 5'-GMP results in increased expression of PPARG protein CTD PMID:20471953 8-Br-cAMP decreases expression ISO RGD:3371 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA CTD PMID:15994020 8-Br-cAMP multiple interactions ISO RGD:3371 6480464 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA] CTD PMID:15994020 9,11,13-octadecatrienoic acid increases expression ISO RGD:69168 6480464 eleostearic acid results in increased expression of PPARG mRNA, eleostearic acid results in increased expression of PPARG protein CTD PMID:15961301 9-cis-retinoic acid multiple interactions ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Alitretinoin results in increased activity of PPARG protein], MG 262 promotes the reaction [Alitretinoin results in increased activity of PPARG protein] CTD PMID:15707588 9-cis-retinoic acid multiple interactions ISO RGD:3371 6480464 [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter], Alitretinoin binds to and results in increased activity of PPARG protein CTD PMID:15150131 , PMID:18063688 9-cis-retinoic acid increases activity ISO RGD:69168 6480464 Alitretinoin results in increased activity of PPARG protein CTD PMID:15707588 9-cis-retinoic acid multiple interactions EXP 6480464 [Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine], PPARG protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA] CTD PMID:16513826 , PMID:17019405 9-HODE increases expression ISO RGD:69168 6480464 9-hydroxy-10, 12-octadecadienoic acid results in increased expression of PPARG CTD PMID:16647253 9E,11E-octadecadienoic acid affects binding ISO RGD:69168 6480464 9, 11-linoleic acid binds to PPARG protein CTD PMID:23843199 9E,11E-octadecadienoic acid increases activity ISO RGD:69168 6480464 9, 11-linoleic acid results in increased activity of PPARG protein CTD PMID:18155510 [6]-Shogaol increases activity EXP 6480464 shogaol results in increased activity of PPARG protein CTD PMID:18577375 AACOCF3 multiple interactions EXP 6480464 arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 acetaldehyde multiple interactions ISO RGD:69168 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 acetic acid decreases expression ISO RGD:3371 6480464 Acetic Acid results in decreased expression of PPARG protein CTD PMID:32045587 acetic acid multiple interactions ISO RGD:3371 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 acetophenone multiple interactions ISO RGD:69168 6480464 acetophenone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 acetylsalicylic acid decreases activity ISO RGD:69168 6480464 Aspirin results in decreased activity of PPARG protein CTD PMID:15646027 acetylsalicylic acid decreases expression ISO RGD:3371 6480464 Aspirin results in decreased expression of PPARG mRNA CTD PMID:18222077 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of PPARG mRNA CTD PMID:19462226 acetylsalicylic acid increases expression ISO RGD:69168 6480464 Aspirin results in increased expression of PPARG more ... CTD PMID:18971601 , PMID:19880272 acetylsalicylic acid multiple interactions ISO RGD:69168 6480464 Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein] CTD PMID:16386710 acrolein multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 acrylamide multiple interactions EXP 6480464 Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA] more ... CTD PMID:30409764 adefovir pivoxil affects activity ISO RGD:69168 6480464 adefovir dipivoxil affects the activity of PPARG protein CTD PMID:25596134 afimoxifene multiple interactions ISO RGD:69168 6480464 afimoxifene inhibits the reaction [PPARG protein binds to CD36 promoter] more ... CTD PMID:27358406 afimoxifene multiple interactions EXP 6480464 PPARG mRNA promotes the reaction [afimoxifene results in decreased expression of CD36 protein] CTD PMID:27358406 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PPARG mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:69168 6480464 Aflatoxin B1 results in decreased methylation of PPARG gene CTD PMID:27153756 AICA ribonucleotide multiple interactions ISO RGD:3371 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 AICA ribonucleotide multiple interactions ISO RGD:69168 6480464 AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] CTD PMID:27688165 aldehydo-D-glucosamine multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 aldehydo-D-glucosamine increases expression ISO RGD:3371 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 aldehydo-D-glucosamine 6-phosphate decreases expression EXP 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 aldehydo-D-glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 , PMID:32407875 aldehydo-D-glucose decreases expression ISO RGD:3371 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 aldehydo-D-glucose multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... aldehydo-D-glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 aldosterone affects abundance EXP 6480464 PPARG protein affects the abundance of Aldosterone CTD PMID:16007095 all-trans-retinoic acid multiple interactions ISO RGD:69168 6480464 [PPARG protein results in increased expression of ALDH1A2 protein] which results in increased chemical synthesis of Tretinoin more ... CTD PMID:16982809 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA] CTD PMID:32473317 all-trans-retinoic acid increases expression ISO RGD:69168 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:21934132 , PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:3371 6480464 Tretinoin results in increased expression of PPARG mRNA, Tretinoin results in increased expression of PPARG protein CTD PMID:14568882 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:17198874 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of PPARG mRNA CTD PMID:11237167 all-trans-retinol multiple interactions ISO RGD:3371 6480464 Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA] CTD PMID:15203375 all-trans-retinol increases expression ISO RGD:3371 6480464 Vitamin A results in increased expression of PPARG mRNA CTD PMID:16180333 allethrin increases expression ISO RGD:69168 6480464 Allethrins results in increased expression of PPARG mRNA CTD PMID:32473317 allethrin increases activity ISO RGD:69168 6480464 Allethrins results in increased activity of PPARG protein CTD PMID:20143881 allyl isothiocyanate multiple interactions ISO RGD:3371 6480464 allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein], allyl isothiocyanate inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein] CTD PMID:30927557 Aloe emodin multiple interactions ISO RGD:69168 6480464 aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] CTD PMID:22645054 alpha-linolenic acid increases expression EXP 6480464 alpha-Linolenic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 alpha-linolenic acid increases activity ISO RGD:69168 6480464 alpha-Linolenic Acid results in increased activity of PPARG protein CTD PMID:20696231 alpha-linolenic acid multiple interactions ISO RGD:69168 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-linolenic acid multiple interactions EXP 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-linolenic acid multiple interactions ISO RGD:3371 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-pinene multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 amiodarone multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA] more ... CTD PMID:21123845 , PMID:24489787 amiodarone increases expression ISO RGD:69168 6480464 Amiodarone results in increased expression of PPARG mRNA CTD PMID:21123845 ammonium chloride affects expression ISO RGD:3371 6480464 Ammonium Chloride affects the expression of PPARG mRNA CTD PMID:16483693 andrographolide multiple interactions EXP 6480464 andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] CTD PMID:27475717 anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO RGD:3371 6480464 pyrazolanthrone results in increased expression of PPARG mRNA, pyrazolanthrone results in increased expression of PPARG protein CTD PMID:17372590 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:3371 6480464 pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein] CTD PMID:28283887 apigenin multiple interactions EXP 6480464 Apigenin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 apigenin decreases expression EXP 6480464 Apigenin results in decreased expression of PPARG mRNA CTD PMID:18359623 arachidonic acid decreases expression ISO RGD:69168 6480464 Arachidonic Acid results in decreased expression of PPARG mRNA, Arachidonic Acid results in decreased expression of PPARG protein CTD PMID:11172467 arachidonic acid multiple interactions EXP 6480464 Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 arachidonic acid increases expression ISO RGD:3371 6480464 Arachidonic Acid results in increased expression of PPARG protein CTD PMID:12604186 Aroclor 1254 increases expression ISO RGD:69168 6480464 Chlorodiphenyl 54% Chlorine results in increased expression of PPARG mRNA CTD PMID:16934159 Aroclor 1254 multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Chlorodiphenyl 54% Chlorine] results in increased expression of PPARG mRNA CTD PMID:23804495 arsane decreases expression ISO RGD:69168 6480464 Arsenic results in decreased expression of PPARG mRNA, Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 arsane affects expression ISO RGD:69168 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 arsane multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 , PMID:28793237 arsenic atom decreases expression ISO RGD:69168 6480464 Arsenic results in decreased expression of PPARG mRNA, Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 arsenic atom affects expression ISO RGD:69168 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 arsenic atom multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 , PMID:28793237 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of PPARG mRNA CTD PMID:15868481 arsenous acid decreases response to substance ISO RGD:69168 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid decreases expression ISO RGD:69168 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 arsenous acid increases expression ISO RGD:69168 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA, Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 , PMID:30362509 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 , PMID:30362509 arsenous acid multiple interactions ISO RGD:69168 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 , PMID:30362509 aspartame multiple interactions EXP 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA CTD PMID:23783067 ATP multiple interactions ISO RGD:69168 6480464 FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]] more ... CTD PMID:26670611 ATP decreases abundance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate, PPARG protein results in decreased abundance of Adenosine Triphosphate CTD PMID:26670611 atrazine multiple interactions EXP 6480464 Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA] CTD PMID:24440342 atrazine multiple interactions ISO RGD:69168 6480464 [Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA CTD PMID:18585445 Aurothioglucose multiple interactions EXP 6480464 [Dietary Fats co-treated with Aurothioglucose] results in decreased expression of PPARG protein CTD PMID:21382165 avobenzone multiple interactions ISO RGD:69168 6480464 avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA], avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:31016361 , PMID:32407875 avobenzone increases expression ISO RGD:69168 6480464 avobenzone results in increased expression of PPARG mRNA CTD PMID:31016361 , PMID:32407875 baicalein decreases expression EXP 6480464 baicalein results in decreased expression of PPARG protein CTD PMID:24560969 baicalin multiple interactions ISO RGD:3371 6480464 baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:24312512 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of PPARG mRNA CTD PMID:19048458 benzene increases expression ISO RGD:69168 6480464 Benzene results in increased expression of PPARG mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:69168 6480464 Benzoapyrene results in decreased expression of PPARG mRNA CTD PMID:20064835 , PMID:30453624 benzo[a]pyrene multiple interactions ISO RGD:69168 6480464 [Soot co-treated with Benzoapyrene] results in decreased activity of PPARG protein CTD PMID:24464499 benzo[a]pyrene multiple interactions EXP 6480464 Benzoapyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein] more ... CTD PMID:27329536 benzo[a]pyrene increases activity EXP 6480464 Benzoapyrene results in increased activity of PPARG protein CTD PMID:27329536 benzo[a]pyrene increases expression ISO RGD:3371 6480464 Benzoapyrene results in increased expression of PPARG mRNA, Benzoapyrene results in increased expression of PPARG protein CTD PMID:20920559 , PMID:22374506 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of PPARG mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of PPARG mRNA CTD PMID:19770486 benzo[a]pyrene multiple interactions ISO RGD:3371 6480464 [Benzoapyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA, [Benzoapyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein CTD PMID:20920559 benzo[a]pyrene increases expression ISO RGD:69168 6480464 Benzoapyrene results in increased expression of PPARG mRNA CTD PMID:15735009 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:69168 6480464 7 more ... CTD PMID:19150397 benzofurans decreases expression EXP 6480464 Benzofurans results in decreased expression of PPARG mRNA, Benzofurans results in decreased expression of PPARG protein CTD PMID:20863820 Benzyl parahydroxybenzoate increases expression EXP 6480464 benzylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 , PMID:27659731 Benzyl parahydroxybenzoate increases activity EXP 6480464 benzylparaben results in increased activity of PPARG protein CTD PMID:28527915 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA] more ... CTD PMID:20564506 berberine increases expression ISO RGD:69168 6480464 Berberine results in increased expression of PPARG mRNA CTD PMID:29408570 berberine multiple interactions ISO RGD:69168 6480464 15-deoxyprostaglandin J2 promotes the reaction [Berberine affects the localization of and results in increased activity of PPARG protein] more ... CTD PMID:29408570 berberine increases response to substance ISO RGD:69168 6480464 PPARG mRNA results in increased susceptibility to Berberine CTD PMID:29408570 berberine decreases expression ISO RGD:69168 6480464 Berberine results in decreased expression of PPARG mRNA CTD PMID:26478571 beta-carotene decreases expression EXP 6480464 beta Carotene results in decreased expression of PPARG mRNA CTD PMID:21569430 beta-D-glucosamine multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 beta-D-glucosamine increases expression ISO RGD:3371 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 beta-D-glucosamine increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 beta-D-glucosamine 6-sulfate decreases expression EXP 6480464 glucosamine 6-O-sulfate results in decreased expression of PPARG mRNA, glucosamine 6-O-sulfate results in decreased expression of PPARG protein CTD PMID:19520133 beta-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 bezafibrate multiple interactions EXP 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA] CTD PMID:21324916 bezafibrate increases expression ISO RGD:69168 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:24759758 bezafibrate affects binding ISO RGD:69168 6480464 Bezafibrate binds to PPARG protein CTD PMID:11779144 , PMID:23843199 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:21324916 bezafibrate increases activity EXP 6480464 Bezafibrate results in increased activity of PPARG protein CTD PMID:12401884 bezafibrate decreases expression ISO RGD:69168 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:15708366 bezafibrate multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]] more ... CTD PMID:11779144 , PMID:21734263 bezafibrate multiple interactions ISO RGD:3371 6480464 Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] CTD PMID:12967931 bezafibrate decreases expression ISO RGD:3371 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:11473052 bifenthrin increases expression ISO RGD:69168 6480464 bifenthrin results in increased expression of PPARG mRNA CTD PMID:29554630 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:3371 6480464 [Benzoapyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA, [Benzoapyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein CTD PMID:20920559 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG mRNA, Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:29669060 , PMID:31211961 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG protein], Diethylhexyl Phthalate binds to and results in decreased activity of PPARG protein CTD PMID:27633901 , PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69168 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:28025108 more ... bis(2-ethylhexyl) phthalate affects binding ISO RGD:69168 6480464 Diethylhexyl Phthalate binds to PPARG protein, Diethylhexyl Phthalate metabolite binds to PPARG protein CTD PMID:23843199 more ... bis(2-ethylhexyl) phthalate affects expression EXP 6480464 Diethylhexyl Phthalate affects the expression of PPARG mRNA CTD PMID:22588786 , PMID:25351189 bis(2-ethylhexyl) phthalate increases expression ISO RGD:3371 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:15647598 more ... bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:21856391 more ... bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:22197818 more ... bis(2-ethylhexyl) phthalate decreases expression ISO RGD:3371 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:16690193 , PMID:29669060 bisdemethoxycurcumin affects binding ISO RGD:69168 6480464 bis4-hydroxycinnamoylmethane binds to PPARG protein CTD PMID:15713005 bisphenol A increases localization ISO RGD:69168 6480464 bisphenol A results in increased localization of PPARG protein CTD PMID:20064783 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:30133442 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PPARG protein CTD PMID:31319301 bisphenol A decreases expression ISO RGD:69168 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:28711546 bisphenol A increases methylation ISO RGD:3371 6480464 bisphenol A results in increased methylation of PPARG gene CTD PMID:28505145 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of PPARG promoter CTD PMID:27334623 bisphenol A increases activity EXP 6480464 bisphenol A results in increased activity of PPARG protein CTD PMID:27273607 bisphenol A decreases expression ISO RGD:3371 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:23399309 more ... bisphenol A affects binding ISO RGD:69168 6480464 bisphenol A analog binds to PPARG protein, bisphenol A binds to PPARG protein CTD PMID:23843199 more ... bisphenol A increases expression ISO RGD:69168 6480464 bisphenol A results in increased expression of PPARG mRNA CTD PMID:20064783 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPARG more ... CTD PMID:18359623 more ... bisphenol A multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] more ... CTD PMID:21622942 more ... bisphenol A multiple interactions ISO RGD:3371 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein more ... CTD PMID:23399309 more ... bisphenol A increases expression ISO RGD:3371 6480464 bisphenol A results in increased expression of PPARG mRNA CTD PMID:20019905 bisphenol A multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein more ... CTD PMID:22197818 more ... Bisphenol A diglycidyl ether multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:11030710 more ... Bisphenol A diglycidyl ether decreases activity ISO RGD:3371 6480464 2, 2-bis4-glycidyloxyphenylpropane results in decreased activity of PPARG protein CTD PMID:27363640 Bisphenol A diglycidyl ether decreases expression ISO RGD:3371 6480464 2, 2-bis4-glycidyloxyphenylpropane results in decreased expression of PPARG protein CTD PMID:22726273 Bisphenol A diglycidyl ether decreases activity ISO RGD:69168 6480464 2, 2-bis4-glycidyloxyphenylpropane results in decreased activity of PPARG protein CTD PMID:21543282 Bisphenol A diglycidyl ether multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:19903033 more ... Bisphenol A diglycidyl ether increases expression EXP 6480464 2, 2-bis4-glycidyloxyphenylpropane results in increased expression of PPARG mRNA CTD PMID:11991651 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:11991651 more ... bisphenol F multiple interactions ISO RGD:69168 6480464 bisphenol F inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 bisphenol F diglycidyl ether multiple interactions ISO RGD:69168 6480464 bisphenol F diglycidyl ether inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of PPARG mRNA CTD PMID:19147827 bleomycin A2 multiple interactions ISO RGD:69168 6480464 Berberine inhibits the reaction [Bleomycin binds to PPARG protein] CTD PMID:29408570 bleomycin A2 multiple interactions EXP 6480464 rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA] CTD PMID:19147827 bongkrekic acid increases activity ISO RGD:69168 6480464 Bongkrekic Acid analog results in increased activity of PPARG protein, Bongkrekic Acid results in increased activity of PPARG protein CTD PMID:25786526 boric acid multiple interactions EXP 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA] more ... CTD PMID:28285642 bosentan decreases expression ISO RGD:69168 6480464 Bosentan results in decreased expression of PPARG mRNA CTD PMID:29761207 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of PPARG protein CTD PMID:19698295 bucladesine multiple interactions EXP 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA, [ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein CTD PMID:19698295 Butylbenzyl phthalate multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:24155963 more ... Butylbenzyl phthalate increases expression EXP 6480464 butylbenzyl phthalate results in increased expression of PPARG mRNA CTD PMID:27923775 Butylbenzyl phthalate increases activity ISO RGD:69168 6480464 butylbenzyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 Butylbenzyl phthalate affects binding ISO RGD:69168 6480464 butylbenzyl phthalate binds to PPARG protein CTD PMID:23843199 , PMID:32407875 Butylbenzyl phthalate multiple interactions ISO RGD:69168 6480464 butylbenzyl phthalate binds to and results in increased activity of PPARG protein, butylbenzyl phthalate inhibits the reaction [GW 1929 binds to PPARG protein] CTD PMID:24155963 , PMID:31016361 Butylparaben increases activity EXP 6480464 butylparaben results in increased activity of PPARG protein CTD PMID:28527915 Butylparaben multiple interactions EXP 6480464 2 more ... CTD PMID:22956630 more ... Butylparaben increases expression ISO RGD:69168 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 more ... Butylparaben multiple interactions ISO RGD:69168 6480464 butylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 Butylparaben increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to butylparaben CTD PMID:28527915 butyric acid increases expression ISO RGD:69168 6480464 Butyric Acid results in increased expression of PPARG mRNA, Butyric Acid results in increased expression of PPARG protein CTD PMID:10833422 butyric acid multiple interactions EXP 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 butyric acid multiple interactions ISO RGD:69168 6480464 [Butyric Acid co-treated with Lipopolysaccharides] results in increased expression of PPARG mRNA CTD PMID:29751049 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of PPARG protein CTD PMID:21848503 cadmium atom increases expression ISO RGD:3371 6480464 Cadmium results in increased expression of PPARG mRNA CTD PMID:25388156 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA, Cadmium Chloride results in decreased expression of PPARG protein CTD PMID:23921151 , PMID:31152847 cadmium dichloride increases expression ISO RGD:3371 6480464 Cadmium Chloride results in increased expression of PPARG protein CTD PMID:28283887 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PPARG mRNA CTD PMID:26352046 cadmium dichloride decreases expression ISO RGD:3371 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA CTD PMID:25993096 cadmium dichloride affects activity ISO RGD:69168 6480464 Cadmium Chloride affects the activity of PPARG protein CTD PMID:25596134 cadmium dichloride multiple interactions ISO RGD:3371 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 , PMID:28283887 cadmium dichloride multiple interactions EXP 6480464 [MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA, [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA CTD PMID:23921151 cadmium sulfate multiple interactions EXP 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PPARG mRNA] CTD PMID:16221973 caffeine decreases expression ISO RGD:3371 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of PPARG mRNA, Calcitriol results in decreased expression of PPARG protein CTD PMID:15036392 more ... calcitriol multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:29953732 cannabidiol increases expression ISO RGD:69168 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:23220503 cannabidiol decreases expression ISO RGD:69168 6480464 Cannabidiol results in decreased expression of PPARG protein CTD PMID:28853159 cannabidiol multiple interactions EXP 6480464 [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of PPARG mRNA CTD PMID:30742662 cannabidiol affects binding EXP 6480464 Cannabidiol binds to PPARG protein CTD PMID:19285060 cannabidiol increases expression ISO RGD:3371 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:19285060 cannabidiol multiple interactions ISO RGD:69168 6480464 Cannabidiol results in increased expression of and affects the localization of PPARG protein, N-2-cyclohexyloxy-4-nitrophenylmethanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein] CTD PMID:23220503 cannabidiolic acid decreases expression ISO RGD:69168 6480464 cannabidiolic acid results in decreased expression of PPARG protein CTD PMID:28853159 cannabidiolic acid increases expression ISO RGD:69168 6480464 cannabidiolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerol increases expression ISO RGD:69168 6480464 cannabigerol results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerol decreases expression ISO RGD:69168 6480464 cannabigerol results in decreased expression of PPARG protein CTD PMID:28853159 cannabigerolic acid increases expression ISO RGD:69168 6480464 cannabigerolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerolic acid decreases expression ISO RGD:69168 6480464 cannabigerolic acid results in decreased expression of PPARG protein CTD PMID:28853159 capsaicin multiple interactions ISO RGD:3371 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:20359164 capsaicin increases activity ISO RGD:69168 6480464 Capsaicin results in increased activity of PPARG protein CTD PMID:15383218 capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of PPARG protein CTD PMID:17295509 capsaicin decreases expression ISO RGD:69168 6480464 Capsaicin results in decreased expression of PPARG mRNA CTD PMID:18769453 capsaicin multiple interactions ISO RGD:69168 6480464 2, 2-bis4-glycidyloxyphenylpropane inhibits the reaction [Capsaicin results in increased activity of PPARG protein] CTD PMID:15383218 carbamazepine affects expression ISO RGD:69168 6480464 Carbamazepine affects the expression of PPARG mRNA CTD PMID:24752500 carbon monoxide multiple interactions EXP 6480464 [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein more ... CTD PMID:22046279 carbon nanotube multiple interactions ISO RGD:69168 6480464 PPARG protein affects the reaction [Nanotubes, Carbon results in increased expression of PLIN2 protein] CTD PMID:32649966 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 , PMID:25926378 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:69168 6480464 Nanotubes more ... CTD PMID:23634900 , PMID:32649966 carnosic acid increases activity ISO RGD:69168 6480464 salvin results in increased activity of PPARG protein CTD PMID:20696231 carotenoid decreases expression EXP 6480464 Carotenoids results in decreased expression of PPARG mRNA CTD PMID:11237167 casticin increases expression ISO RGD:69168 6480464 casticin results in increased expression of PPARG mRNA CTD PMID:27862857 celastrol affects expression EXP 6480464 tripterine affects the expression of PPARG mRNA, tripterine affects the expression of PPARG protein CTD PMID:27085773 celecoxib multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein] more ... CTD PMID:19522023 , PMID:23943857 celecoxib multiple interactions EXP 6480464 [Celecoxib co-treated with docetaxel] results in increased expression of PPARG protein CTD PMID:16052515 celecoxib multiple interactions ISO RGD:3371 6480464 Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:19247274 celecoxib increases expression ISO RGD:69168 6480464 Celecoxib results in increased expression of PPARG mRNA, Celecoxib results in increased expression of PPARG protein CTD PMID:23943857 celecoxib affects localization ISO RGD:69168 6480464 Celecoxib affects the localization of PPARG protein CTD PMID:23943857 cerulenin decreases expression EXP 6480464 Cerulenin results in decreased expression of PPARG mRNA CTD PMID:15707987 ceruletide multiple interactions EXP 6480464 PPARG affects the reaction [Ceruletide results in increased expression of CCL2 mRNA], PPARG affects the reaction [Ceruletide results in increased expression of CXCL1 mRNA] CTD PMID:17463185 chalcone increases expression EXP 6480464 Chalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 chenodeoxycholic acid increases expression ISO RGD:69168 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:27174168 chenodeoxycholic acid increases expression ISO RGD:3371 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:15980055 chloroacetaldehyde affects activity ISO RGD:69168 6480464 chloroacetaldehyde affects the activity of PPARG protein CTD PMID:25596134 chlorogenic acid increases expression EXP 6480464 Chlorogenic Acid results in increased expression of PPARG mRNA CTD PMID:21870829 chlorogenic acid decreases expression ISO RGD:69168 6480464 Chlorogenic Acid results in decreased expression of PPARG mRNA CTD PMID:20706672 chlorpromazine affects activity ISO RGD:3371 6480464 Chlorpromazine affects the activity of PPARG protein CTD PMID:25596134 chlorpyrifos decreases expression ISO RGD:69168 6480464 Chlorpyrifos results in decreased expression of PPARG mRNA, Chlorpyrifos results in decreased expression of PPARG protein CTD PMID:24793810 , PMID:31509763 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein, Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:32017950 chlorpyrifos multiple interactions ISO RGD:69168 6480464 rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein] CTD PMID:24793810 cholesterol multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol] more ... CTD PMID:12044893 more ... cholesterol multiple interactions EXP 6480464 [Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA more ... CTD PMID:18302760 more ... choline multiple interactions EXP 6480464 3 more ... CTD PMID:18991162 , PMID:28973532 chrysin multiple interactions EXP 6480464 chrysin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 cidofovir anhydrous affects activity ISO RGD:69168 6480464 Cidofovir affects the activity of PPARG protein CTD PMID:25596134 ciglitazone multiple interactions EXP 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA more ... CTD PMID:12847270 more ... ciglitazone affects localization ISO RGD:3371 6480464 ciglitazone affects the localization of PPARG protein CTD PMID:20578043 ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of PPARG protein CTD PMID:19698295 ciglitazone decreases response to substance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased susceptibility to ciglitazone CTD PMID:19922793 ciglitazone affects binding ISO RGD:69168 6480464 ciglitazone binds to PPARG protein CTD PMID:12839938 , PMID:21511917 ciglitazone increases localization ISO RGD:69168 6480464 ciglitazone results in increased localization of PPARG protein CTD PMID:12517972 ciglitazone increases activity ISO RGD:69168 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:12517972 more ... ciglitazone increases activity EXP 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:11683414 , PMID:16023420 ciglitazone multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:16820301 , PMID:18063688 ciglitazone increases expression ISO RGD:69168 6480464 ciglitazone results in increased expression of PPARG mRNA, ciglitazone results in increased expression of PPARG protein CTD PMID:11840453 more ... ciglitazone multiple interactions ISO RGD:69168 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ABHD3 mRNA more ... CTD PMID:11030710 more ... cilnidipine decreases activity ISO RGD:69168 6480464 cilnidipine results in decreased activity of PPARG protein CTD PMID:25257666 cilostazol increases activity ISO RGD:69168 6480464 cilostazol results in increased activity of PPARG protein CTD PMID:21660147 cilostazol multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [cilostazol results in increased activity of PPARG protein] more ... CTD PMID:21660147 cinnamic acid increases expression EXP 6480464 cinnamic acid results in increased expression of PPARG mRNA CTD PMID:21870829 cis-caffeic acid increases expression EXP 6480464 caffeic acid results in increased expression of PPARG mRNA CTD PMID:21870829 cisplatin multiple interactions ISO RGD:69168 6480464 [rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin more ... CTD PMID:21781307 , PMID:27417252 cisplatin affects activity ISO RGD:69168 6480464 Cisplatin affects the activity of PPARG protein CTD PMID:25596134 cisplatin decreases expression ISO RGD:69168 6480464 Cisplatin results in decreased expression of PPARG protein CTD PMID:27417252 cisplatin affects expression ISO RGD:69168 6480464 Cisplatin affects the expression of PPARG mRNA CTD PMID:23300844 cisplatin decreases expression ISO RGD:3371 6480464 Cisplatin results in decreased expression of PPARG mRNA, Cisplatin results in decreased expression of PPARG protein CTD PMID:22989705 , PMID:31103702 cisplatin multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:22989705 , PMID:31103702 Citreoviridin multiple interactions ISO RGD:3371 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein], Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 Citreoviridin decreases activity ISO RGD:3371 6480464 citreoviridin results in decreased activity of PPARG protein CTD PMID:31419397 citronellol increases activity ISO RGD:69168 6480464 citronellol results in increased activity of PPARG protein CTD PMID:21597168 citronellol multiple interactions ISO RGD:69168 6480464 citronellol inhibits the reaction [PPARG protein results in increased expression of PTGS2 mRNA] CTD PMID:21597168 Clinofibrate affects binding ISO RGD:69168 6480464 clinofibrate binds to PPARG protein CTD PMID:11779144 clodronic acid affects activity ISO RGD:69168 6480464 Clodronic Acid affects the activity of PPARG protein CTD PMID:25596134 clofazimine increases expression ISO RGD:3371 6480464 Clofazimine results in increased expression of PPARG mRNA, Clofazimine results in increased expression of PPARG protein CTD PMID:31393584 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA more ... CTD PMID:9543393 clofibrate increases expression ISO RGD:3371 6480464 Clofibrate results in increased expression of PPARG mRNA, Clofibrate results in increased expression of PPARG protein CTD PMID:12604186 , PMID:12699904 clofibrate multiple interactions ISO RGD:3371 6480464 PPARG protein promotes the reaction [Clofibrate results in decreased expression of ALDH3A1 mRNA] CTD PMID:12604186 clofibrate affects response to substance ISO RGD:3371 6480464 PPARG protein affects the susceptibility to Clofibrate CTD PMID:12604186 clofibrate multiple interactions ISO RGD:69168 6480464 Clofibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 clofibrate increases response to substance ISO RGD:3371 6480464 PPARG results in increased susceptibility to Clofibrate CTD PMID:12699904 clofibric acid affects binding ISO RGD:69168 6480464 Clofibric Acid binds to PPARG protein CTD PMID:11779144 Clofop increases activity ISO RGD:69168 6480464 fenofibric acid results in increased activity of PPARG protein CTD PMID:15273253 Clofop multiple interactions ISO RGD:69168 6480464 fenofibric acid results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 Clofop affects binding ISO RGD:69168 6480464 fenofibric acid binds to PPARG protein CTD PMID:11779144 clozapine multiple interactions EXP 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA], Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein] CTD PMID:20564506 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PPARG mRNA, Clozapine results in increased expression of PPARG protein CTD PMID:20564506 cobalt dichloride decreases expression ISO RGD:69168 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:15708366 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:20594416 colforsin daropate hydrochloride decreases expression ISO RGD:69168 6480464 Colforsin results in decreased expression of PPARG mRNA CTD PMID:31278978 conjugated linoleic acid decreases activity ISO RGD:69168 6480464 Linoleic Acids, Conjugated results in decreased activity of PPARG protein CTD PMID:18776171 conjugated linoleic acid increases expression EXP 6480464 Linoleic Acids, Conjugated results in increased expression of PPARG mRNA CTD PMID:17322064 conjugated linoleic acid increases expression ISO RGD:69168 6480464 Linoleic Acids more ... CTD PMID:15961301 conjugated linoleic acid multiple interactions ISO RGD:69168 6480464 Linoleic Acids more ... CTD PMID:18776171 conjugated linoleic acid decreases expression ISO RGD:69168 6480464 Linoleic Acids, Conjugated results in decreased expression of PPARG protein CTD PMID:16933788 copper atom multiple interactions ISO RGD:69168 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:69168 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 corticosterone multiple interactions EXP 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 cortisone multiple interactions EXP 6480464 2-3-benzoyl-4-hydroxy-1 more ... CTD PMID:21315688 cortisone increases expression EXP 6480464 Cortisone results in increased expression of PPARG mRNA CTD PMID:21315688 crocidolite asbestos increases expression ISO RGD:69168 6480464 Asbestos more ... CTD PMID:23634900 cucurbitacin B multiple interactions EXP 6480464 STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA] CTD PMID:24316209 cucurbitacin B decreases expression EXP 6480464 cucurbitacin B results in decreased expression of PPARG mRNA CTD PMID:24316209 cucurbitacin I decreases expression EXP 6480464 cucurbitacin I results in decreased expression of PPARG mRNA CTD PMID:24316209 curcumin affects binding ISO RGD:69168 6480464 Curcumin binds to PPARG protein CTD PMID:15713005 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of PPARG mRNA CTD PMID:23603106 curcumin increases expression ISO RGD:3371 6480464 Curcumin results in increased expression of PPARG mRNA, Curcumin results in increased expression of PPARG protein CTD PMID:16959952 more ... curcumin increases activity ISO RGD:3371 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:18332871 curcumin decreases expression ISO RGD:3371 6480464 Curcumin results in decreased expression of PPARG protein CTD PMID:19225048 curcumin affects localization ISO RGD:3371 6480464 Curcumin affects the localization of PPARG protein CTD PMID:17531121 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] more ... CTD PMID:19297423 more ... curcumin multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:16782535 more ... curcumin multiple interactions ISO RGD:69168 6480464 PPARG protein promotes the reaction [Curcumin results in decreased expression of CCN2 mRNA] CTD PMID:17965732 curcumin increases activity ISO RGD:69168 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:15486348 curcumin decreases expression ISO RGD:69168 6480464 Curcumin results in decreased expression of PPARG protein modified form CTD PMID:15486348 cyanamide multiple interactions ISO RGD:69168 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 cyanocob(III)alamin multiple interactions ISO RGD:3371 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA], Vitamin B 12 inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 cyclophosphamide increases expression ISO RGD:3371 6480464 Cyclophosphamide results in increased expression of PPARG mRNA CTD PMID:27281708 cyclophosphamide multiple interactions ISO RGD:3371 6480464 Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of PPARG mRNA] CTD PMID:25446862 cyclophosphamide decreases expression ISO RGD:3371 6480464 Cyclophosphamide results in decreased expression of PPARG mRNA CTD PMID:25446862 cyclosporin A multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein CTD PMID:17016853 cyclosporin A affects activity ISO RGD:3371 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 cyclosporin A affects activity ISO RGD:69168 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:3371 6480464 Cyclosporine results in decreased expression of PPARG mRNA, Cyclosporine results in decreased expression of PPARG protein CTD PMID:17461532 cyclosporin A multiple interactions ISO RGD:3371 6480464 Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein] more ... CTD PMID:17461532 cyclosporin A increases expression ISO RGD:69168 6480464 Cyclosporine results in increased expression of PPARG mRNA CTD PMID:20106945 cyhalothrin increases expression ISO RGD:3371 6480464 cyhalothrin results in increased expression of PPARG mRNA CTD PMID:27348886 cytarabine multiple interactions EXP 6480464 2, 2-bis4-glycidyloxyphenylpropane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA] CTD PMID:23264188 cytarabine increases expression EXP 6480464 Cytarabine results in increased expression of PPARG mRNA CTD PMID:23264188 D-glucose multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... D-glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 D-glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 , PMID:32407875 D-glucose decreases expression ISO RGD:3371 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 daunorubicin decreases activity ISO RGD:69168 6480464 Daunorubicin results in decreased activity of PPARG protein CTD PMID:25257666 daunorubicin increases expression ISO RGD:3371 6480464 Daunorubicin results in increased expression of PPARG protein CTD PMID:20888384 daunorubicin multiple interactions ISO RGD:3371 6480464 telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] CTD PMID:20888384 DDE multiple interactions ISO RGD:69168 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA CTD PMID:26200599 DDT increases expression ISO RGD:69168 6480464 DDT results in increased expression of PPARG mRNA CTD PMID:25014179 DDT multiple interactions EXP 6480464 DDT results in increased activity of and results in increased localization of PPARG protein CTD PMID:11911853 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of PPARG protein CTD PMID:30743236 decanoic acid increases activity ISO RGD:69168 6480464 decanoic acid results in increased activity of PPARG protein CTD PMID:24998974 decanoic acid affects binding ISO RGD:69168 6480464 decanoic acid binds to PPARG protein CTD PMID:24998974 Delta(9)-tetrahydrocannabinolic acid increases expression ISO RGD:69168 6480464 delta9-tetrahydrocannabinolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 Delta(9)-tetrahydrocannabinolic acid decreases expression ISO RGD:69168 6480464 delta9-tetrahydrocannabinolic acid results in decreased expression of PPARG protein CTD PMID:28853159 Delta(9)-tetrahydrocannabinolic acid multiple interactions ISO RGD:69168 6480464 delta9-tetrahydrocannabinolic acid inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:28853159 delta-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 demethoxycurcumin affects binding ISO RGD:69168 6480464 demethoxycurcumin binds to PPARG protein CTD PMID:15713005 deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of PPARG mRNA CTD PMID:23911798 deoxynivalenol multiple interactions ISO RGD:69168 6480464 15-deoxy-delta12 more ... CTD PMID:18485432 deoxynivalenol decreases activity ISO RGD:69168 6480464 deoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 deoxynivalenol increases expression ISO RGD:69168 6480464 deoxynivalenol results in increased expression of PPARG mRNA CTD PMID:18485432 dexamethasone multiple interactions EXP 6480464 +-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... dexamethasone increases expression ISO RGD:69168 6480464 Dexamethasone results in increased expression of PPARG mRNA, Dexamethasone results in increased expression of PPARG protein CTD PMID:16569937 more ... dexamethasone increases expression ISO RGD:3371 6480464 Dexamethasone results in increased expression of PPARG mRNA, Dexamethasone results in increased expression of PPARG protein CTD PMID:14568882 , PMID:19118567 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of PPARG mRNA, Dexamethasone results in increased expression of PPARG mRNA alternative form CTD PMID:16814746 more ... dexamethasone multiple interactions ISO RGD:3371 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA more ... CTD PMID:16782535 , PMID:21350315 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of PPARG mRNA CTD PMID:16889531 dexamethasone multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:17290005 more ... dextran sulfate increases expression EXP 6480464 Dextran Sulfate results in increased expression of PPARG protein CTD PMID:23261717 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA CTD PMID:29950665 Di-n-decyl phthalate affects binding ISO RGD:69168 6480464 didecyl phthalate binds to PPARG protein CTD PMID:23843199 Di-n-hexyl phthalate affects binding ISO RGD:69168 6480464 di-n-hexyl phthalate binds to PPARG protein CTD PMID:23843199 diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of PPARG mRNA, diallyl trisulfide results in decreased expression of PPARG protein CTD PMID:22137902 diallyl trisulfide multiple interactions EXP 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein] more ... CTD PMID:22137902 diallyl trisulfide decreases activity EXP 6480464 diallyl trisulfide results in decreased activity of PPARG protein CTD PMID:22137902 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 , PMID:30362509 diarsenic trioxide decreases response to substance ISO RGD:69168 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 , PMID:30362509 diarsenic trioxide decreases expression ISO RGD:69168 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 diarsenic trioxide multiple interactions ISO RGD:69168 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 , PMID:30362509 diarsenic trioxide increases expression ISO RGD:69168 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA, Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 diazinon increases activity ISO RGD:69168 6480464 Diazinon results in increased activity of PPARG protein CTD PMID:28728110 dibutyl phthalate multiple interactions ISO RGD:69168 6480464 Dibutyl Phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:27633901 dibutyl phthalate increases expression ISO RGD:69168 6480464 Dibutyl Phthalate results in increased expression of PPARG protein CTD PMID:29061543 dibutyl phthalate increases activity ISO RGD:69168 6480464 Dibutyl Phthalate results in increased activity of PPARG protein CTD PMID:26172262 dibutyl phthalate affects binding ISO RGD:69168 6480464 Dibutyl Phthalate binds to PPARG protein CTD PMID:23843199 dibutylstannane multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of PPARG mRNA] CTD PMID:29787037 dibutylstannane increases expression ISO RGD:69168 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 dibutylstannane increases expression EXP 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of PPARG mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:69168 6480464 Diclofenac affects the expression of PPARG mRNA CTD PMID:24752500 diclofenac multiple interactions ISO RGD:69168 6480464 Diclofenac inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 diclofenac increases activity ISO RGD:69168 6480464 Diclofenac results in increased activity of PPARG protein CTD PMID:12065695 more ... diethyl phthalate affects binding ISO RGD:69168 6480464 diethyl phthalate binds to PPARG protein CTD PMID:23843199 diethylstilbestrol multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein] more ... CTD PMID:22710028 , PMID:26944108 diethylstilbestrol increases activity EXP 6480464 Diethylstilbestrol results in increased activity of PPARG protein CTD PMID:22710028 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of PPARG mRNA, Diethylstilbestrol results in increased expression of PPARG protein CTD PMID:22710028 diheptyl phthalate affects binding ISO RGD:69168 6480464 diheptyl phthalate binds to PPARG protein CTD PMID:23843199 diisobutyl phthalate multiple interactions ISO RGD:69168 6480464 diisobutyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:27633901 diisobutyl phthalate increases expression ISO RGD:69168 6480464 diisobutyl phthalate results in increased expression of PPARG protein CTD PMID:29061543 diisobutyl phthalate increases activity ISO RGD:69168 6480464 diisobutyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 Diisodecyl phthalate affects binding ISO RGD:69168 6480464 diisodecyl phthalate binds to PPARG protein CTD PMID:23843199 Diisodecyl phthalate multiple interactions ISO RGD:69168 6480464 diisodecyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 Diisodecyl phthalate increases expression EXP 6480464 diisodecyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 diisononyl phthalate affects binding ISO RGD:69168 6480464 diisononyl phthalate binds to PPARG protein CTD PMID:23843199 diisononyl phthalate increases expression EXP 6480464 diisononyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 diisononyl phthalate multiple interactions ISO RGD:69168 6480464 diisononyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 diisononyl phthalate affects activity ISO RGD:69168 6480464 diisononyl phthalate affects the activity of PPARG protein CTD PMID:26172262 Dimethyl phthalate affects binding ISO RGD:69168 6480464 dimethyl phthalate binds to PPARG protein CTD PMID:23843199 dimethyl sulfoxide decreases expression ISO RGD:69168 6480464 Dimethyl Sulfoxide results in decreased expression of PPARG mRNA CTD PMID:21878375 dimethylarsinic acid decreases expression ISO RGD:69168 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 dimethylarsinic acid multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA CTD PMID:28793237 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 diosgenin increases expression EXP 6480464 Diosgenin results in increased expression of PPARG protein CTD PMID:24001619 diosgenin decreases response to substance EXP 6480464 PPARG protein results in decreased susceptibility to Diosgenin CTD PMID:26408789 diosgenin multiple interactions EXP 6480464 [Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein more ... CTD PMID:26408789 diosgenin decreases expression EXP 6480464 Diosgenin results in decreased expression of PPARG mRNA CTD PMID:26408789 dioxygen decreases expression ISO RGD:69168 6480464 Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:19520921 dioxygen increases expression ISO RGD:69168 6480464 Oxygen deficiency results in increased expression of PPARG mRNA CTD PMID:26516004 dioxygen affects activity ISO RGD:69168 6480464 Oxygen deficiency affects the activity of PPARG protein CTD PMID:25596134 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of PPARG protein, Oxygen results in increased expression of PPARG mRNA CTD PMID:21113404 , PMID:22535284 dioxygen decreases expression ISO RGD:3371 6480464 Oxygen results in decreased expression of PPARG mRNA, Oxygen results in decreased expression of PPARG protein CTD PMID:16617452 dioxygen multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:16617452 more ... dioxygen multiple interactions EXP 6480464 [Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form more ... CTD PMID:16814746 more ... dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of PPARG mRNA, Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:21531777 dipentyl phthalate affects binding ISO RGD:69168 6480464 di-n-pentyl phthalate binds to PPARG protein CTD PMID:23843199 dipropyl phthalate affects binding ISO RGD:69168 6480464 di-n-propylphthalate binds to PPARG protein CTD PMID:23843199 disodium selenite multiple interactions ISO RGD:3371 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA], Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:21705299 , PMID:31419397 disodium selenite increases activity ISO RGD:3371 6480464 Sodium Selenite results in increased activity of PPARG protein CTD PMID:31419397 disodium selenite increases expression ISO RGD:3371 6480464 Sodium Selenite results in increased expression of PPARG protein CTD PMID:24140496 disulfiram affects expression ISO RGD:69168 6480464 Disulfiram affects the expression of PPARG mRNA CTD PMID:32712770 diuron increases expression ISO RGD:3371 6480464 Diuron results in increased expression of PPARG mRNA CTD PMID:21551480 doramapimod increases expression EXP 6480464 BIRB 796 results in increased expression of PPARG mRNA CTD PMID:21328587 dorsomorphin multiple interactions ISO RGD:69168 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:24584901 , PMID:27188386 doxorubicin decreases activity ISO RGD:69168 6480464 Doxorubicin results in decreased activity of PPARG protein CTD PMID:25257666 doxorubicin decreases expression ISO RGD:3371 6480464 Doxorubicin results in decreased expression of PPARG protein CTD PMID:30836069 doxorubicin multiple interactions ISO RGD:3371 6480464 caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein], iodopravadoline inhibits the reaction [caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein]] CTD PMID:30836069 doxorubicin decreases expression ISO RGD:69168 6480464 Doxorubicin results in decreased expression of PPARG mRNA, Doxorubicin results in decreased expression of PPARG protein CTD PMID:27417252 , PMID:29803840 doxorubicin multiple interactions ISO RGD:69168 6480464 [15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin, [nimesulide co-treated with Doxorubicin] results in increased expression of PPARG CTD PMID:14567645 , PMID:23964924 efavirenz decreases expression ISO RGD:69168 6480464 efavirenz results in decreased expression of PPARG mRNA CTD PMID:21619898 elemental selenium multiple interactions EXP 6480464 PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide more ... CTD PMID:17439952 ellagic acid increases expression ISO RGD:69168 6480464 Ellagic Acid results in increased expression of PPARG protein CTD PMID:23811531 emodin increases expression ISO RGD:69168 6480464 Emodin results in increased expression of PPARG protein CTD PMID:25448808 emodin multiple interactions ISO RGD:69168 6480464 Emodin results in increased stability of and results in increased expression of PPARG mRNA CTD PMID:25448808 enalapril decreases expression ISO RGD:3371 6480464 Enalapril results in decreased expression of PPARG protein CTD PMID:19225048 enalapril multiple interactions ISO RGD:3371 6480464 Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] CTD PMID:30623541 endosulfan increases expression ISO RGD:3371 6480464 Endosulfan results in increased expression of PPARG mRNA CTD PMID:29391264 endrin decreases expression EXP 6480464 Endrin results in decreased expression of PPARG protein CTD PMID:10385688 epoxomicin multiple interactions EXP 6480464 epoxomicin inhibits the reaction [resveratrol results in decreased expression of PPARG protein], epoxomicin inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein] CTD PMID:18555852 esculetin multiple interactions ISO RGD:3371 6480464 esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein], esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein] CTD PMID:21450970 esculetin multiple interactions EXP 6480464 esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA] CTD PMID:27769711 ethanol multiple interactions ISO RGD:69168 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 , PMID:24144995 ethanol decreases expression ISO RGD:69168 6480464 Ethanol results in decreased expression of PPARG protein CTD PMID:28062356 ethanol decreases expression ISO RGD:3371 6480464 [Ethanol results in decreased expression of PPARG protein] which results in decreased expression of ADIPOQ protein more ... CTD PMID:24412557 ethanol increases expression ISO RGD:3371 6480464 Ethanol results in increased expression of PPARG mRNA CTD PMID:18793633 more ... ethanol increases expression EXP 6480464 Ethanol results in increased expression of PPARG mRNA, Ethanol results in increased expression of PPARG protein CTD PMID:18620774 more ... ethanol increases expression ISO RGD:69168 6480464 Ethanol results in increased expression of PPARG mRNA CTD PMID:24144995 ethanol affects expression EXP 6480464 Ethanol affects the expression of PPARG mRNA CTD PMID:19167417 ethanol multiple interactions EXP 6480464 [ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of PPARG mRNA more ... CTD PMID:18755807 more ... ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PPARG mRNA CTD PMID:22173916 ethanol multiple interactions ISO RGD:3371 6480464 [Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA more ... CTD PMID:15318101 more ... ethyl 3,4-dihydroxybenzoate multiple interactions EXP 6480464 ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:24338020 ethyl myristate multiple interactions ISO RGD:69168 6480464 ethyl myristate binds to and results in decreased activity of PPARG protein CTD PMID:27633901 ethylparaben increases expression EXP 6480464 ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA CTD PMID:22956630 eugenol multiple interactions ISO RGD:69168 6480464 Eugenol analog binds to and results in increased activity of PPARG protein CTD PMID:20064974 eugenol increases expression EXP 6480464 Eugenol results in increased expression of PPARG mRNA CTD PMID:21870829 eugenol multiple interactions EXP 6480464 2 more ... CTD PMID:20064974 Evodiamine decreases expression EXP 6480464 evodiamine results in decreased expression of PPARG CTD PMID:17884939 farnesol multiple interactions ISO RGD:69168 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA CTD PMID:30611723 farnesol increases expression ISO RGD:69168 6480464 Farnesol analog results in increased expression of PPARG mRNA CTD PMID:30611723 fenchone multiple interactions ISO RGD:69168 6480464 fenchone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 fenofibrate increases expression ISO RGD:69168 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:28034800 fenofibrate affects activity ISO RGD:3371 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 fenofibrate affects activity ISO RGD:69168 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 fenofibrate multiple interactions ISO RGD:69168 6480464 [Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA CTD PMID:24534255 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 fenoprofen multiple interactions ISO RGD:69168 6480464 Fenoprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 fenthion increases expression ISO RGD:69168 6480464 Fenthion results in increased expression of PPARG mRNA CTD PMID:32473317 fentin chloride multiple interactions ISO RGD:69168 6480464 diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein] more ... CTD PMID:19497422 fentin chloride increases activity ISO RGD:69168 6480464 triphenyltin chloride results in increased activity of PPARG protein CTD PMID:26172262 fentin hydroxide increases expression ISO RGD:69168 6480464 triphenyltin hydroxide results in increased expression of PPARG mRNA CTD PMID:32473317 ferulic acid increases expression EXP 6480464 ferulic acid results in increased expression of PPARG mRNA CTD PMID:21870829 fipronil increases expression EXP 6480464 fipronil results in increased expression of PPARG mRNA, fipronil results in increased expression of PPARG protein CTD PMID:27103584 flavanone increases expression ISO RGD:69168 6480464 flavanone results in increased expression of PPARG protein CTD PMID:22056764 flavonoids decreases expression ISO RGD:3371 6480464 Flavonoids results in decreased expression of PPARG mRNA CTD PMID:23238999 fluconazole increases expression ISO RGD:3371 6480464 Fluconazole results in increased expression of PPARG mRNA CTD PMID:20623750 flufenamic acid multiple interactions ISO RGD:69168 6480464 [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein, Flufenamic Acid binds to and results in increased activity of PPARG protein CTD PMID:10866999 , PMID:9013583 flufenamic acid increases activity ISO RGD:69168 6480464 Flufenamic Acid results in increased activity of PPARG protein CTD PMID:10866999 fluoxastrobin multiple interactions ISO RGD:69168 6480464 fluoxastrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 fluoxetine multiple interactions ISO RGD:69168 6480464 Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein] CTD PMID:25766885 fluprostenol multiple interactions EXP 6480464 fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA] CTD PMID:21236357 fluticasone multiple interactions ISO RGD:69168 6480464 Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] CTD PMID:15531761 flutolanil increases activity ISO RGD:69168 6480464 flutolanil results in increased activity of PPARG protein CTD PMID:20143881 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 folic acid multiple interactions ISO RGD:3371 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA], Folic Acid inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 fomepizole multiple interactions ISO RGD:69168 6480464 fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 fructose increases expression ISO RGD:3371 6480464 Fructose results in increased expression of PPARG mRNA CTD PMID:19196556 fructose decreases activity ISO RGD:3371 6480464 Fructose results in decreased activity of PPARG protein CTD PMID:25679220 fructose multiple interactions ISO RGD:3371 6480464 [Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein more ... CTD PMID:19196556 more ... fucoxanthin decreases expression EXP 6480464 fucoxanthin results in decreased expression of PPARG mRNA CTD PMID:20519145 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein], fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA] CTD PMID:22710028 , PMID:26408789 fumonisin B2 decreases activity ISO RGD:69168 6480464 fumonisin B2 results in decreased activity of PPARG protein CTD PMID:27481073 furan decreases expression ISO RGD:3371 6480464 furan results in decreased expression of PPARG mRNA CTD PMID:25539665 , PMID:26194646 Fusarenone X decreases activity ISO RGD:69168 6480464 fusarenon-X results in decreased activity of PPARG protein CTD PMID:27481073 gallic acid increases expression EXP 6480464 Gallic Acid results in increased expression of PPARG protein CTD PMID:24036142 gallic acid increases activity ISO RGD:3371 6480464 Gallic Acid results in increased activity of PPARG protein CTD PMID:24433871 gallocatechin decreases expression ISO RGD:3371 6480464 gallocatechol results in decreased expression of PPARG mRNA CTD PMID:21877759 gamma-linolenic acid multiple interactions ISO RGD:69168 6480464 gamma-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:15318936 gamma-tocopherol increases expression ISO RGD:69168 6480464 gamma-Tocopherol results in increased expression of PPARG mRNA, gamma-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 gamma-tocopherol multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 gemcitabine affects expression EXP 6480464 gemcitabine affects the expression of PPARG mRNA CTD PMID:19427843 gemfibrozil increases expression ISO RGD:69168 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 genistein decreases expression EXP 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:18359623 genistein increases expression ISO RGD:3371 6480464 Genistein results in increased expression of PPARG mRNA CTD PMID:24361872 genistein decreases expression ISO RGD:69168 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:20706672 genistein increases activity ISO RGD:3371 6480464 Genistein results in increased activity of PPARG protein CTD PMID:19903033 genistein multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:19903033 , PMID:27171397 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [[lipopolysaccharide more ... CTD PMID:30550845 geraniol multiple interactions ISO RGD:3371 6480464 geraniol inhibits the reaction [Fructose results in decreased activity of PPARG protein] more ... CTD PMID:25679220 , PMID:26165751 geraniol increases activity ISO RGD:69168 6480464 geraniol results in increased activity of PPARG protein CTD PMID:21597168 geraniol decreases expression ISO RGD:69168 6480464 geraniol results in decreased expression of PPARG mRNA CTD PMID:27683099 gingerol multiple interactions EXP 6480464 gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA] more ... CTD PMID:22285432 , PMID:26498061 gingerol decreases expression EXP 6480464 gingerol results in decreased expression of PPARG mRNA, gingerol results in decreased expression of PPARG protein CTD PMID:26498061 ginsenoside Re increases expression EXP 6480464 ginsenoside Re results in increased expression of PPARG mRNA CTD PMID:23545455 gliclazide multiple interactions ISO RGD:3371 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 glucose multiple interactions ISO RGD:3371 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 , PMID:32407875 glucose decreases expression ISO RGD:3371 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 glyburide multiple interactions ISO RGD:3371 6480464 Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA], Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:29223569 glycerol multiple interactions ISO RGD:3371 6480464 ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein] CTD PMID:16820301 glycerol decreases expression ISO RGD:3371 6480464 Glycerol results in decreased expression of PPARG protein CTD PMID:16820301 glycerol 2-phosphate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 , PMID:32473317 glycerol 2-phosphate multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 glycine increases expression EXP 6480464 Glycine results in increased expression of PPARG mRNA CTD PMID:18930730 glycycoumarin affects binding ISO RGD:69168 6480464 glycycoumarin binds to PPARG protein CTD PMID:14608046 glycyrrhetinate multiple interactions ISO RGD:3371 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 glycyrrhetinic acid multiple interactions ISO RGD:3371 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 gossypetin affects response to substance EXP 6480464 PPARG protein affects the susceptibility to gossypetin CTD PMID:23845592 griseofulvin increases expression EXP 6480464 Griseofulvin results in increased expression of PPARG mRNA CTD PMID:9548566 GW 1929 increases activity ISO RGD:69168 6480464 GW 1929 results in increased activity of PPARG protein CTD PMID:21543282 GW 1929 increases expression ISO RGD:3371 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:19420904 GW 1929 multiple interactions EXP 6480464 4-chloro-N-2-5-trifluoromethyl-2-pyridylsulfonylethylbenzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA] more ... CTD PMID:12847270 more ... GW 1929 increases expression EXP 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:20516370 GW 1929 multiple interactions ISO RGD:69168 6480464 [GW 1929 binds to and results in increased activity of PPARG protein] promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein] more ... CTD PMID:20008677 more ... GW 1929 affects binding ISO RGD:69168 6480464 GW 1929 binds to PPARG protein CTD PMID:20008677 more ... GW 4064 increases expression ISO RGD:3371 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:15980055 GW 4064 multiple interactions ISO RGD:69168 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of PPARG mRNA CTD PMID:30611723 GW 4064 increases expression ISO RGD:69168 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:30611723 GW 501516 increases expression ISO RGD:69168 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 GW 501516 increases expression EXP 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 GW 501516 increases activity ISO RGD:69168 6480464 GW 501516 results in increased activity of PPARG protein CTD PMID:16386710 GW 7647 multiple interactions ISO RGD:69168 6480464 GW 7647 binds to and results in increased activity of PPARG protein, PPARG protein promotes the reaction [GW 7647 results in increased activity of DIO2 protein] CTD PMID:19036883 GW 7647 multiple interactions EXP 6480464 [PPARA protein co-treated with GW 7647] results in increased expression of PPARG mRNA CTD PMID:21324916 GW 7647 increases activity ISO RGD:69168 6480464 GW 7647 results in increased activity of PPARG protein CTD PMID:20143881 harmine multiple interactions EXP 6480464 [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA CTD PMID:20519739 harmine increases expression EXP 6480464 Harmine results in increased expression of PPARG protein CTD PMID:27805061 hesperetin decreases expression ISO RGD:69168 6480464 hesperetin results in decreased expression of PPARG mRNA, hesperetin results in decreased expression of PPARG protein CTD PMID:25345581 hesperetin multiple interactions EXP 6480464 [hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein] more ... CTD PMID:28428136 hesperidin multiple interactions ISO RGD:3371 6480464 Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]] more ... CTD PMID:24954035 more ... hesperidin multiple interactions EXP 6480464 Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein] CTD PMID:16427799 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of PPARG mRNA, Palmitic Acid results in increased expression of PPARG protein CTD PMID:18154422 , PMID:30208301 hexadecanoic acid multiple interactions ISO RGD:69168 6480464 ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]], trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] CTD PMID:30208301 hexadecanoic acid increases expression ISO RGD:69168 6480464 Palmitic Acid results in increased expression of PPARG protein CTD PMID:30208301 hexadecanoic acid multiple interactions EXP 6480464 trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] CTD PMID:30208301 hexadecanoic acid multiple interactions ISO RGD:3371 6480464 [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:25048947 more ... hexadecanoic acid decreases expression ISO RGD:3371 6480464 Palmitic Acid results in decreased expression of PPARG mRNA CTD PMID:25108154 hispidulin multiple interactions EXP 6480464 hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA], hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein] CTD PMID:30055130 Honokiol multiple interactions ISO RGD:69168 6480464 ALOX15 protein promotes the reaction [honokiol results in decreased expression of PPARG protein], honokiol binds to and results in increased activity of PPARG protein CTD PMID:20649594 , PMID:23811337 Honokiol decreases expression EXP 6480464 honokiol results in decreased expression of PPARG protein CTD PMID:20649594 Honokiol decreases expression ISO RGD:69168 6480464 honokiol results in decreased expression of PPARG mRNA, honokiol results in decreased expression of PPARG protein CTD PMID:20649594 hydrazine decreases expression ISO RGD:3371 6480464 hydrazine results in decreased expression of PPARG mRNA CTD PMID:15370871 hydrazines decreases expression EXP 6480464 Hydrazines results in decreased expression of PPARG mRNA, Hydrazines results in decreased expression of PPARG protein CTD PMID:21647536 hydrogen peroxide increases expression ISO RGD:69168 6480464 Hydrogen Peroxide results in increased expression of PPARG mRNA CTD PMID:25130202 hydrogen peroxide increases degradation ISO RGD:69168 6480464 Hydrogen Peroxide results in increased degradation of PPARG protein CTD PMID:25305479 hydrogen peroxide decreases expression ISO RGD:69168 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:27417252 hydrogen peroxide affects abundance EXP 6480464 PPARG protein affects the abundance of Hydrogen Peroxide CTD PMID:18083318 hydrogen peroxide decreases abundance EXP 6480464 PPARG gene polymorphism results in decreased abundance of Hydrogen Peroxide CTD PMID:18083318 hydrogen peroxide multiple interactions ISO RGD:3371 6480464 stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] CTD PMID:17302992 hydrogen peroxide decreases expression ISO RGD:3371 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:17302992 hydrogen peroxide affects expression ISO RGD:69168 6480464 Hydrogen Peroxide affects the expression of PPARG mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:69168 6480464 Hydrogen Peroxide results in increased phosphorylation of and results in decreased activity of PPARG protein more ... CTD PMID:17030193 more ... hydroxysafflor yellow A multiple interactions ISO RGD:3371 6480464 hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]] more ... CTD PMID:24192212 hydroxytyrosol decreases expression EXP 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of PPARG mRNA CTD PMID:21569430 ibuprofen multiple interactions EXP 6480464 Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA], Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein] CTD PMID:16407166 , PMID:18946735 ibuprofen affects activity ISO RGD:3371 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 ibuprofen affects activity ISO RGD:69168 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of PPARG mRNA CTD PMID:16407166 ibuprofen increases activity ISO RGD:3371 6480464 Ibuprofen analog results in increased activity of PPARG protein CTD PMID:11755111 ibuprofen multiple interactions ISO RGD:69168 6480464 Ibuprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 idarubicin decreases activity ISO RGD:69168 6480464 Idarubicin results in decreased activity of PPARG protein CTD PMID:25257666 ifosfamide affects activity ISO RGD:69168 6480464 Ifosfamide affects the activity of PPARG protein CTD PMID:25596134 indinavir decreases expression EXP 6480464 Indinavir results in decreased expression of PPARG mRNA CTD PMID:17926646 indole-3-methanol affects expression ISO RGD:3371 6480464 indole-3-carbinol affects the expression of PPARG mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:12485869 more ... indometacin multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA more ... CTD PMID:30055130 indometacin increases activity ISO RGD:69168 6480464 Indomethacin analog results in increased activity of PPARG protein, Indomethacin results in increased activity of PPARG protein CTD PMID:12065695 more ... indometacin increases activity ISO RGD:3371 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11755111 indometacin multiple interactions ISO RGD:3371 6480464 Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein] CTD PMID:12897060 indometacin increases activity EXP 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11683414 indometacin increases expression ISO RGD:69168 6480464 Indomethacin results in increased expression of PPARG mRNA, Indomethacin results in increased expression of PPARG protein CTD PMID:12483719 more ... indometacin affects localization ISO RGD:69168 6480464 Indomethacin affects the localization of PPARG protein CTD PMID:15899809 Ingenol 3,20-dibenzoate increases activity ISO RGD:69168 6480464 ingenol dibenzoate results in increased activity of PPARG protein CTD PMID:15707588 iohexol increases expression ISO RGD:69168 6480464 Iohexol results in increased expression of PPARG mRNA CTD PMID:29705293 iprodione increases activity ISO RGD:69168 6480464 iprodione results in increased activity of PPARG protein CTD PMID:20143881 iron atom increases expression ISO RGD:69168 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:69168 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 isoliquiritigenin multiple interactions EXP 6480464 isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein] CTD PMID:27117918 isoniazide decreases expression EXP 6480464 Isoniazid results in decreased expression of PPARG mRNA, Isoniazid results in decreased expression of PPARG protein CTD PMID:24128855 isoniazide decreases expression ISO RGD:69168 6480464 Isoniazid results in decreased expression of PPARG mRNA CTD PMID:24128855 isonicotinamide decreases expression EXP 6480464 isonicotinamide results in decreased expression of PPARG mRNA CTD PMID:16813520 isophorone multiple interactions ISO RGD:69168 6480464 isophorone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 isoprenaline multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein] more ... CTD PMID:24954035 , PMID:30623541 isoprenaline decreases expression ISO RGD:3371 6480464 Isoproterenol results in decreased expression of PPARG mRNA, Isoproterenol results in decreased expression of PPARG protein CTD PMID:24286936 , PMID:30623541 isoprenaline multiple interactions EXP 6480464 osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] CTD PMID:21854795 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of PPARG mRNA CTD PMID:21854795 isorhamnetin multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein], 3-methylquercetin binds to and results in increased activity of PPARG protein CTD PMID:22992727 isorhamnetin increases expression ISO RGD:69168 6480464 3-methylquercetin results in increased expression of PPARG protein CTD PMID:22992727 isotretinoin increases expression ISO RGD:3371 6480464 Isotretinoin results in increased expression of PPARG mRNA CTD PMID:19041696 , PMID:19212007 ivermectin multiple interactions EXP 6480464 Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein], Rosiglitazone affects the reaction [Ivermectin affects the expression of PPARG mRNA] CTD PMID:31199990 ivermectin affects expression EXP 6480464 Ivermectin affects the expression of PPARG mRNA CTD PMID:31199990 juglone increases expression ISO RGD:69168 6480464 juglone results in increased expression of PPARG mRNA, juglone results in increased expression of PPARG protein CTD PMID:31916655 juglone multiple interactions ISO RGD:69168 6480464 [Indomethacin co-treated with juglone] results in increased expression of PPARG mRNA, [Indomethacin co-treated with juglone] results in increased expression of PPARG protein CTD PMID:31916655 kaempferol multiple interactions EXP 6480464 kaempferol binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 , PMID:18262572 kaempferol increases expression ISO RGD:69168 6480464 kaempferol results in increased expression of PPARG mRNA, kaempferol results in increased expression of PPARG protein CTD PMID:25765892 kresoxim-methyl multiple interactions ISO RGD:69168 6480464 kresoxim-methyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 , PMID:32473317 L-ascorbic acid multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 L-methionine multiple interactions EXP 6480464 3 more ... CTD PMID:18991162 , PMID:28973532 lacidipine increases activity ISO RGD:69168 6480464 lacidipine results in increased activity of PPARG protein CTD PMID:25257666 lead diacetate multiple interactions ISO RGD:3371 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 , PMID:28283887 lead diacetate increases expression ISO RGD:3371 6480464 lead acetate results in increased expression of PPARG protein CTD PMID:28283887 lead(0) increases expression ISO RGD:3371 6480464 Lead results in increased expression of PPARG mRNA CTD PMID:23086611 lead(0) increases expression EXP 6480464 Lead results in increased expression of PPARG, Lead results in increased expression of PPARG mRNA CTD PMID:23086611 , PMID:26518054 lead(2+) increases expression ISO RGD:3371 6480464 Lead results in increased expression of PPARG mRNA CTD PMID:23086611 lead(2+) increases expression EXP 6480464 Lead results in increased expression of PPARG, Lead results in increased expression of PPARG mRNA CTD PMID:23086611 , PMID:26518054 leflunomide increases expression ISO RGD:69168 6480464 leflunomide results in increased expression of PPARG mRNA CTD PMID:28988120 Licarin A multiple interactions EXP 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA, [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein CTD PMID:29288687 linoleamide increases activity ISO RGD:69168 6480464 linoleamide analog results in increased activity of PPARG protein CTD PMID:29288688 linoleic acid affects binding ISO RGD:69168 6480464 Linoleic Acid binds to PPARG protein CTD PMID:23843199 linoleic acid affects binding EXP 6480464 Linoleic Acid binds to PPARG protein CTD PMID:12021203 linoleic acid multiple interactions ISO RGD:3371 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 linoleic acid increases expression EXP 6480464 Linoleic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 linoleic acid multiple interactions EXP 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 linoleic acid multiple interactions ISO RGD:69168 6480464 resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein] CTD PMID:25672876 linoleic acid increases expression ISO RGD:69168 6480464 Linoleic Acid results in increased expression of PPARG protein CTD PMID:25672876 linoleic acid increases activity ISO RGD:69168 6480464 Linoleic Acid results in increased activity of PPARG protein CTD PMID:25786526 linoleic acid decreases expression ISO RGD:69168 6480464 Linoleic Acid results in decreased expression of PPARG mRNA, Linoleic Acid results in decreased expression of PPARG protein CTD PMID:11172467 , PMID:15708366 lipoic acid multiple interactions ISO RGD:3371 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 lipopolysaccharide multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:15318101 more ... lipopolysaccharide decreases activity ISO RGD:3371 6480464 Lipopolysaccharides results in decreased activity of PPARG protein CTD PMID:29480285 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA, Lipopolysaccharides results in decreased expression of PPARG protein CTD PMID:16847310 more ... lipopolysaccharide decreases expression ISO RGD:69168 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA CTD PMID:12604364 lipopolysaccharide multiple interactions ISO RGD:69168 6480464 15-deoxy-delta12 more ... CTD PMID:12604364 more ... lipopolysaccharide multiple interactions EXP 6480464 15-deoxy-delta12 more ... CTD PMID:11343698 more ... lipopolysaccharide increases activity EXP 6480464 Lipopolysaccharides results in increased activity of PPARG protein CTD PMID:27329536 lipoxin A4 multiple interactions ISO RGD:3371 6480464 lipoxin A4 binds to and results in increased activity of PPARG protein CTD PMID:19321784 lithium chloride increases expression ISO RGD:69168 6480464 Lithium Chloride results in increased expression of PPARG mRNA CTD PMID:23527032 losartan multiple interactions ISO RGD:3371 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of PPARG mRNA] CTD PMID:19109942 losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA] CTD PMID:18302760 lovastatin affects localization ISO RGD:69168 6480464 Lovastatin analog affects the localization of PPARG protein CTD PMID:26863638 lovastatin multiple interactions ISO RGD:3371 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] more ... CTD PMID:20578043 lovastatin increases expression ISO RGD:3371 6480464 Lovastatin results in increased expression of PPARG mRNA CTD PMID:20578043 lovastatin multiple interactions EXP 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of PPARG mRNA, PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein] CTD PMID:16425225 , PMID:29852127 lovastatin multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein] more ... CTD PMID:16425225 , PMID:26863638 luzindole multiple interactions ISO RGD:69168 6480464 luzindole inhibits the reaction [Melatonin results in increased expression of PPARG protein], luzindole inhibits the reaction [Pioglitazone results in increased expression of PPARG protein] CTD PMID:29734669 LY294002 increases expression ISO RGD:3371 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA, 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG protein CTD PMID:17372590 m-xylene decreases expression ISO RGD:3371 6480464 3-xylene results in decreased expression of PPARG mRNA CTD PMID:12815608 Magnolol multiple interactions EXP 6480464 2 more ... CTD PMID:20064974 Magnolol multiple interactions ISO RGD:69168 6480464 magnolol binds to and results in increased activity of PPARG protein CTD PMID:20064974 manganese atom multiple interactions ISO RGD:3371 6480464 [1, 1-bis3'-indolyl-1-4-trifluoromethylphenylmethane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 manganese(0) multiple interactions ISO RGD:3371 6480464 [1, 1-bis3'-indolyl-1-4-trifluoromethylphenylmethane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 mangiferin multiple interactions ISO RGD:3371 6480464 mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA], mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:29223569 mangiferin multiple interactions EXP 6480464 [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein CTD PMID:32417366 manidipine decreases activity ISO RGD:69168 6480464 manidipine results in decreased activity of PPARG protein CTD PMID:25257666 melatonin decreases expression ISO RGD:69168 6480464 Melatonin results in decreased expression of PPARG mRNA CTD PMID:20738756 melatonin multiple interactions ISO RGD:69168 6480464 GW 1929 inhibits the reaction [Melatonin results in increased expression of PPARG protein] more ... CTD PMID:29734669 melatonin increases expression ISO RGD:69168 6480464 Melatonin results in increased expression of PPARG protein CTD PMID:29734669 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of PPARG mRNA, Mercuric Chloride results in decreased expression of PPARG protein CTD PMID:12883084 , PMID:22019852 mercury dichloride increases expression ISO RGD:3371 6480464 Mercuric Chloride results in increased expression of PPARG mRNA CTD PMID:30807803 mesalamine multiple interactions ISO RGD:69168 6480464 [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased expression of PPARG protein, Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with ] results in increased expression of PPARG protein] CTD PMID:27818126 metformin decreases expression ISO RGD:69168 6480464 Metformin results in decreased expression of PPARG mRNA CTD PMID:20956498 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [IL13 protein results in increased expression of PPARG mRNA] CTD PMID:26497364 metformin affects activity ISO RGD:3371 6480464 Metformin affects the activity of PPARG protein CTD PMID:25596134 metformin multiple interactions ISO RGD:3371 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein], Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 , PMID:30256492 metformin increases expression EXP 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:21870829 metformin increases expression ISO RGD:3371 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:20724125 methamphetamine multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine] more ... CTD PMID:17019405 , PMID:18946735 methamphetamine increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to Methamphetamine CTD PMID:17019405 methamphetamine increases activity EXP 6480464 Methamphetamine results in increased activity of PPARG protein CTD PMID:17019405 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PPARG protein CTD PMID:17019405 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of PPARG protein CTD PMID:18946735 methotrexate multiple interactions ISO RGD:3371 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] more ... CTD PMID:25187349 , PMID:28414158 methotrexate decreases expression ISO RGD:3371 6480464 Methotrexate results in decreased expression of PPARG mRNA, Methotrexate results in decreased expression of PPARG protein CTD PMID:28414158 methotrexate increases expression ISO RGD:3371 6480464 Methotrexate results in increased expression of PPARG protein CTD PMID:25187349 methyl beta-cyclodextrin multiple interactions EXP 6480464 methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]] CTD PMID:16971554 methyl laurate multiple interactions ISO RGD:69168 6480464 lauric acid methyl ester binds to and results in decreased activity of PPARG protein CTD PMID:27633901 methyl oleate multiple interactions ISO RGD:69168 6480464 methyl oleate binds to and results in increased activity of PPARG protein CTD PMID:27633901 methylglyoxal multiple interactions ISO RGD:3371 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-N-7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 methylisothiazolinone increases expression ISO RGD:69168 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of PPARG mRNA CTD PMID:31629900 methylparaben multiple interactions ISO RGD:69168 6480464 methylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 methylparaben multiple interactions EXP 6480464 PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA] CTD PMID:28527915 methylparaben increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to methylparaben CTD PMID:28527915 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA], Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] CTD PMID:22956630 , PMID:27145005 mifepristone multiple interactions ISO RGD:3371 6480464 Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein] CTD PMID:30229846 mifepristone decreases expression ISO RGD:3371 6480464 Mifepristone results in decreased expression of PPARG mRNA CTD PMID:25972201 miquelianin increases expression ISO RGD:69168 6480464 quercetin 3-O-glucuronide results in increased expression of PPARG mRNA CTD PMID:25765892 monascin increases response to substance ISO RGD:3371 6480464 PPARG protein results in increased susceptibility to monascin CTD PMID:23954466 monascin increases expression ISO RGD:69168 6480464 monascin results in increased expression of PPARG protein CTD PMID:22381257 monascin multiple interactions ISO RGD:3371 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-N-7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 monascin affects localization ISO RGD:69168 6480464 monascin affects the localization of PPARG protein CTD PMID:23954466 monascin decreases phosphorylation ISO RGD:69168 6480464 monascin results in decreased phosphorylation of PPARG protein CTD PMID:22381257 mono(2-ethyl-5-oxohexyl) phthalate multiple interactions ISO RGD:69168 6480464 mono2-ethyl-5-oxohexylphthalate binds to and affects the folding of and results in increased activity of PPARG protein CTD PMID:30085373 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:12927354 more ... mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [monoethyl phthalate co-treated with mono-2-ethylhexylphthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 mono(2-ethylhexyl) phthalate affects activity ISO RGD:69168 6480464 mono-2-ethylhexylphthalate affects the activity of PPARG protein CTD PMID:30810372 mono(2-ethylhexyl) phthalate affects expression ISO RGD:69168 6480464 mono-2-ethylhexylphthalate affects the expression of PPARG mRNA CTD PMID:30810372 mono(2-ethylhexyl) phthalate increases activity ISO RGD:69168 6480464 mono-2-ethylhexylphthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-2-ethylhexylphthalate results in decreased expression of PPARG mRNA CTD PMID:25543134 mono(2-ethylhexyl) phthalate affects binding ISO RGD:69168 6480464 mono-2-ethylhexylphthalate binds to PPARG protein CTD PMID:23843199 mono(2-ethylhexyl) phthalate increases activity EXP 6480464 mono-2-ethylhexylphthalate analog results in increased activity of PPARG protein, mono-2-ethylhexylphthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... mono(2-ethylhexyl) phthalate decreases expression ISO RGD:69168 6480464 mono-2-ethylhexylphthalate results in decreased expression of PPARG mRNA CTD PMID:23118965 mono(2-ethylhexyl) phthalate increases expression ISO RGD:3371 6480464 mono-2-ethylhexylphthalate results in increased expression of PPARG mRNA, mono-2-ethylhexylphthalate results in increased expression of PPARG protein CTD PMID:15647598 monobenzyl phthalate affects binding ISO RGD:69168 6480464 mono-benzyl phthalate binds to PPARG protein CTD PMID:23843199 monobenzyl phthalate multiple interactions EXP 6480464 [monoethyl phthalate co-treated with mono-2-ethylhexylphthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 monobenzyl phthalate increases expression ISO RGD:69168 6480464 mono-benzyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 monobenzyl phthalate increases activity ISO RGD:69168 6480464 mono-benzyl phthalate results in increased activity of PPARG protein CTD PMID:27551952 Monobutylphthalate affects binding ISO RGD:69168 6480464 monobutyl phthalate binds to PPARG protein CTD PMID:23843199 Monobutylphthalate affects expression ISO RGD:69168 6480464 monobutyl phthalate affects the expression of PPARG mRNA CTD PMID:28381288 Monobutylphthalate increases expression ISO RGD:69168 6480464 monobutyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 Monobutylphthalate multiple interactions ISO RGD:69168 6480464 monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein] CTD PMID:16326050 monocrotophos increases expression ISO RGD:3371 6480464 Monocrotophos results in increased expression of PPARG mRNA CTD PMID:32267039 monoethyl phthalate affects binding ISO RGD:69168 6480464 monoethyl phthalate binds to PPARG protein CTD PMID:23843199 monoethyl phthalate multiple interactions EXP 6480464 [monoethyl phthalate co-treated with mono-2-ethylhexylphthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 monoethyl phthalate affects expression ISO RGD:69168 6480464 monoethyl phthalate affects the expression of PPARG mRNA CTD PMID:28381288 monohexyl phthalate affects binding ISO RGD:69168 6480464 mono-n-hexyl phthalate binds to PPARG protein CTD PMID:23843199 Monomethyl phthalate affects binding ISO RGD:69168 6480464 monomethyl phthalate binds to PPARG protein CTD PMID:23843199 monooctyl phthalate affects binding ISO RGD:69168 6480464 mono-n-octyl phthalate binds to PPARG protein CTD PMID:23843199 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of PPARG mRNA CTD PMID:21205225 monosodium L-glutamate multiple interactions EXP 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA CTD PMID:23783067 monosodium L-glutamate affects response to substance EXP 6480464 PPARG protein affects the susceptibility to Sodium Glutamate CTD PMID:15231871 myricitrin multiple interactions ISO RGD:69168 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA] CTD PMID:25130202 N-acetyl-L-cysteine increases expression ISO RGD:3371 6480464 Acetylcysteine results in increased expression of PPARG mRNA, Acetylcysteine results in increased expression of PPARG protein CTD PMID:17602960 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein], Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein] CTD PMID:22046279 , PMID:27117918 N-acetyl-L-cysteine multiple interactions ISO RGD:69168 6480464 Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species], Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] CTD PMID:16945329 , PMID:23964924 N-acetyl-L-cysteine multiple interactions ISO RGD:3371 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA], Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG protein] CTD PMID:17602960 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases activity ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of PPARG protein CTD PMID:15707588 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of PPARG protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein] CTD PMID:18555852 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [15-deoxy-delta12 more ... CTD PMID:15707588 N-butylbenzenesulfonamide multiple interactions ISO RGD:69168 6480464 N-butylbenzenesulfonamide binds to and results in decreased activity of PPARG protein CTD PMID:27633901 N-methyl-4-phenylpyridinium affects expression ISO RGD:69168 6480464 1-Methyl-4-phenylpyridinium affects the expression of PPARG mRNA CTD PMID:24767308 N-methyl-4-phenylpyridinium decreases expression ISO RGD:69168 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein CTD PMID:26141122 , PMID:30965670 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:69168 6480464 [1-Methyl-4-phenylpyridinium co-treated with PPARGC1A protein] results in increased expression of PPARG mRNA more ... CTD PMID:26141122 , PMID:30965670 N-methyl-N-nitrosourea increases response to substance EXP 6480464 PPARG gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:15930296 N-methylnicotinate multiple interactions ISO RGD:69168 6480464 ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]], trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] CTD PMID:30208301 N-methylnicotinate multiple interactions EXP 6480464 trigonelline inhibits the reaction [[Cholesterol more ... CTD PMID:30208301 N-nitrosodiethylamine decreases expression ISO RGD:3371 6480464 Diethylnitrosamine results in decreased expression of PPARG mRNA, Diethylnitrosamine results in decreased expression of PPARG protein CTD PMID:24954034 N-nitrosodiethylamine multiple interactions ISO RGD:3371 6480464 [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA more ... CTD PMID:28935427 , PMID:30298849 N-nitrosodiethylamine decreases response to substance EXP 6480464 PPARG protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:20512989 N-nitrosodimethylamine decreases expression ISO RGD:3371 6480464 Dimethylnitrosamine results in decreased expression of PPARG mRNA CTD PMID:12055599 , PMID:15099470 NAD zwitterion decreases activity ISO RGD:3371 6480464 NAD results in decreased activity of PPARG protein CTD PMID:18815186 NAD zwitterion multiple interactions ISO RGD:3371 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 NAD(+) multiple interactions ISO RGD:3371 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 NAD(+) decreases activity ISO RGD:3371 6480464 NAD results in decreased activity of PPARG protein CTD PMID:18815186 naproxen increases activity ISO RGD:3371 6480464 Naproxen results in increased activity of PPARG protein CTD PMID:11755111 naringin multiple interactions EXP 6480464 naringin affects the reaction [LEPR protein affects the expression of PPARG protein], naringin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:16427799 , PMID:22198281 naringin multiple interactions ISO RGD:3371 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA], naringin inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA] CTD PMID:30130594 nevirapine increases expression ISO RGD:69168 6480464 Nevirapine results in increased expression of PPARG mRNA CTD PMID:21619898 Nicardipine decreases activity ISO RGD:69168 6480464 Nicardipine results in decreased activity of PPARG protein CTD PMID:25257666 nickel atom decreases expression ISO RGD:69168 6480464 Nickel results in decreased expression of PPARG mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:69168 6480464 nickel sulfate results in increased expression of PPARG mRNA CTD PMID:16314067 nicotinamide multiple interactions EXP 6480464 Niacinamide affects the reaction [PPARG protein binds to NCOR1 protein], resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein] CTD PMID:22539994 nicotinamide increases expression EXP 6480464 Niacinamide results in increased expression of PPARG protein CTD PMID:22539994 nicotine increases expression EXP 6480464 Nicotine results in increased expression of PPARG mRNA CTD PMID:31622651 nicotinic acid multiple interactions ISO RGD:69168 6480464 4-benzhydryloxy-1-3-1H-tetrazol-5-yl--propylpiperidine inhibits the reaction [Niacin results in increased activity of PPARG protein] more ... CTD PMID:15037193 , PMID:16386710 nicotinic acid increases expression ISO RGD:69168 6480464 Niacin results in increased expression of PPARG mRNA CTD PMID:15037193 more ... nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of PPARG mRNA CTD PMID:19797938 nicotinic acid multiple interactions EXP 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA more ... CTD PMID:19797938 , PMID:21236357 Niflumic acid increases expression ISO RGD:69168 6480464 Niflumic Acid results in increased expression of PPARG protein CTD PMID:21067863 nimesulide multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]] more ... CTD PMID:11840453 more ... nimesulide multiple interactions ISO RGD:3371 6480464 nimesulide inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:19247274 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of PPARG mRNA CTD PMID:15705899 nimesulide multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA] CTD PMID:15705899 nimesulide increases expression ISO RGD:69168 6480464 nimesulide results in increased expression of PPARG protein CTD PMID:14977856 nimesulide decreases expression ISO RGD:69168 6480464 nimesulide results in decreased expression of PPARG mRNA CTD PMID:11840453 nitric oxide multiple interactions ISO RGD:69168 6480464 [rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide CTD PMID:16527820 nitric oxide multiple interactions ISO RGD:3371 6480464 [1, 1-bis3'-indolyl-1-4-trifluoromethylphenylmethane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 nitric oxide increases expression ISO RGD:3371 6480464 Nitric Oxide deficiency results in increased expression of PPARG protein CTD PMID:17063326 nitric oxide multiple interactions EXP 6480464 15-deoxy-delta12 more ... CTD PMID:12847270 nitrofen decreases expression ISO RGD:3371 6480464 nitrofen results in decreased expression of PPARG mRNA, nitrofen results in decreased expression of PPARG protein CTD PMID:22595559 Nivalenol decreases activity ISO RGD:69168 6480464 nivalenol results in decreased activity of PPARG protein CTD PMID:27481073 nonanedioic acid increases expression ISO RGD:69168 6480464 azelaic acid results in increased expression of PPARG mRNA CTD PMID:20545756 nonanedioic acid increases activity ISO RGD:69168 6480464 azelaic acid results in increased activity of PPARG protein CTD PMID:20545756 Nonylphenol decreases expression ISO RGD:3371 6480464 nonylphenol results in decreased expression of PPARG protein CTD PMID:29641977 norathyriol multiple interactions ISO RGD:69168 6480464 norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein] CTD PMID:18393431 notoginsenoside R1 multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [notoginsenoside R1 results in increased expression of PPARG] CTD PMID:25714973 notoginsenoside R1 increases expression EXP 6480464 notoginsenoside R1 results in increased expression of PPARG CTD PMID:25714973 NS-398 multiple interactions ISO RGD:69168 6480464 N-2-cyclohexyloxy-4-nitrophenylmethanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein] more ... CTD PMID:11840453 more ... NS-398 increases localization ISO RGD:69168 6480464 N-2-cyclohexyloxy-4-nitrophenylmethanesulfonamide results in increased localization of PPARG protein CTD PMID:12517972 NS-398 decreases expression ISO RGD:69168 6480464 N-2-cyclohexyloxy-4-nitrophenylmethanesulfonamide results in decreased expression of PPARG mRNA CTD PMID:11840453 o-cresol increases expression ISO RGD:3371 6480464 2-cresol results in increased expression of PPARG mRNA CTD PMID:21705299 o-cresol multiple interactions ISO RGD:3371 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA] CTD PMID:21705299 obeticholic acid increases expression ISO RGD:3371 6480464 obeticholic acid results in increased expression of PPARG mRNA, obeticholic acid results in increased expression of PPARG protein CTD PMID:15980055 ochratoxin A decreases expression ISO RGD:69168 6480464 ochratoxin A results in decreased expression of PPARG CTD PMID:20590410 ochratoxin A increases expression ISO RGD:3371 6480464 ochratoxin A results in increased expression of PPARG mRNA CTD PMID:15994020 ochratoxin A multiple interactions ISO RGD:3371 6480464 15-deoxy-delta12 more ... CTD PMID:15994020 ochratoxin A increases phosphorylation ISO RGD:69168 6480464 ochratoxin A results in increased phosphorylation of PPARG protein CTD PMID:20590410 ochratoxin A decreases activity ISO RGD:69168 6480464 ochratoxin A results in decreased activity of PPARG protein CTD PMID:20590410 , PMID:27481073 octadecanoic acid multiple interactions ISO RGD:3371 6480464 stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] CTD PMID:17302992 octanoic acid multiple interactions EXP 6480464 [octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form, [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] CTD PMID:14984747 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of PPARG protein alternative form CTD PMID:17651982 oleamide increases activity ISO RGD:69168 6480464 oleylamide analog results in increased activity of PPARG protein CTD PMID:29288688 oleic acid increases expression EXP 6480464 Oleic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 oleic acid multiple interactions ISO RGD:3371 6480464 [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:25048947 more ... oleic acid multiple interactions ISO RGD:69168 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA more ... CTD PMID:24534255 more ... oleic acid affects binding ISO RGD:69168 6480464 Oleic Acid binds to PPARG protein CTD PMID:24998974 oleic acid increases expression ISO RGD:69168 6480464 Oleic Acid results in increased expression of PPARG mRNA, Oleic Acid results in increased expression of PPARG protein CTD PMID:11172467 oleoyl-CoA multiple interactions ISO RGD:69168 6480464 oleoyl-coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 oleuropein multiple interactions ISO RGD:3371 6480464 oleuropein inhibits the reaction [Cholesterol, Dietary results in increased expression of PPARG protein] CTD PMID:27019295 orientin multiple interactions EXP 6480464 orientin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] CTD PMID:32044341 Osajin decreases expression ISO RGD:69168 6480464 osajin results in decreased expression of PPARG mRNA CTD PMID:20706672 osthole increases expression EXP 6480464 osthol results in increased expression of PPARG mRNA, osthol results in increased expression of PPARG protein CTD PMID:19682441 osthole multiple interactions EXP 6480464 osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] CTD PMID:21854795 oxaliplatin multiple interactions ISO RGD:3371 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:3371 6480464 oxaliplatin results in increased expression of PPARG mRNA CTD PMID:25729387 oxaprozin increases activity ISO RGD:69168 6480464 oxaprozin results in increased activity of PPARG protein CTD PMID:12065695 oxybenzone multiple interactions ISO RGD:69168 6480464 oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA], oxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein] CTD PMID:32407875 oxybenzone increases expression ISO RGD:69168 6480464 oxybenzone results in increased expression of PPARG mRNA CTD PMID:32407875 oxybenzone affects binding ISO RGD:69168 6480464 oxybenzone binds to PPARG protein CTD PMID:32407875 ozone increases expression ISO RGD:3371 6480464 Ozone results in increased expression of PPARG mRNA CTD PMID:16716893 , PMID:29329427 ozone multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:3371 6480464 Fish Oils inhibits the reaction [Ozone results in increased expression of PPARG mRNA] CTD PMID:29329427 p-tolualdehyde multiple interactions ISO RGD:69168 6480464 4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 palmitoyl-CoA multiple interactions ISO RGD:69168 6480464 Palmitoyl Coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PPARG mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:69168 6480464 Acetaminophen results in increased expression of PPARG mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:69168 6480464 Acetaminophen results in decreased expression of PPARG mRNA CTD PMID:26690555 paracetamol affects expression ISO RGD:3371 6480464 Acetaminophen affects the expression of PPARG mRNA CTD PMID:16701773 paraquat decreases response to substance EXP 6480464 PPARG gene polymorphism results in decreased susceptibility to Paraquat CTD PMID:18083318 paraquat decreases expression ISO RGD:3371 6480464 Paraquat results in decreased expression of PPARG mRNA, Paraquat results in decreased expression of PPARG protein CTD PMID:30797787 paraquat multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA]] more ... CTD PMID:30797787 paraquat increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to Paraquat CTD PMID:18083318 paricalcitol multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 PCB138 multiple interactions EXP 6480464 2 more ... CTD PMID:29704545 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:29704545 PD 0325901 multiple interactions EXP 6480464 PD 0325901 inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:26670611 penconazole increases expression EXP 6480464 penconazole results in increased expression of PPARG mRNA CTD PMID:31733957 pentachloronitrobenzene increases activity ISO RGD:69168 6480464 quintozene results in increased activity of PPARG protein CTD PMID:20143881 perflubutane affects binding ISO RGD:69168 6480464 perfluorobutane binds to PPARG protein CTD PMID:24998974 perfluorobutanesulfonic acid increases expression EXP 6480464 perfluorobutanesulfonic acid results in increased expression of PPARG mRNA, perfluorobutanesulfonic acid results in increased expression of PPARG protein CTD PMID:30031040 perfluorobutyric acid increases activity ISO RGD:69168 6480464 perfluorobutyric acid results in increased activity of PPARG protein CTD PMID:24998974 perfluorodecanoic acid increases activity ISO RGD:69168 6480464 perfluorodecanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorododecanoic acid increases activity ISO RGD:69168 6480464 perfluorododecanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorohexanesulfonic acid affects binding ISO RGD:69168 6480464 perfluorohexanesulfonic acid binds to PPARG protein CTD PMID:24998974 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of PPARG mRNA CTD PMID:28049043 perfluorohexanoic acid increases activity ISO RGD:69168 6480464 perfluorohexanoic acid results in increased activity of PPARG protein CTD PMID:23391484 perfluorononanoic acid increases expression ISO RGD:3371 6480464 perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:19196829 , PMID:19878704 perfluorononanoic acid increases expression ISO RGD:69168 6480464 perfluorononanoic acid results in increased expression of PPARG mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid increases activity ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in increased activity of PPARG protein CTD PMID:24998974 perfluorooctane-1-sulfonic acid affects expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid affects the expression of PPARG mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid decreases acetylation ISO RGD:3371 6480464 perfluorooctane sulfonic acid results in decreased acetylation of PPARG protein CTD PMID:28973641 perfluorooctane-1-sulfonic acid increases expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:22269386 more ... perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:23500012 , PMID:26548598 perfluorooctane-1-sulfonic acid increases expression ISO RGD:3371 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:23500012 perfluorooctanoic acid multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to perfluorooctanoic acid, perfluorooctanoic acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 , PMID:23978332 perfluorooctanoic acid increases expression ISO RGD:69168 6480464 perfluorooctanoic acid results in increased expression of PPARG mRNA CTD PMID:25868421 , PMID:28558994 perfluorooctanoic acid increases activity ISO RGD:69168 6480464 perfluorooctanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorooctanoic acid affects binding ISO RGD:69168 6480464 perfluorooctanoic acid binds to PPARG protein CTD PMID:24998974 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PPARG mRNA CTD PMID:22154759 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of PPARG mRNA CTD PMID:22154759 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PPARG mRNA, perfluorooctanoic acid results in increased expression of PPARG protein CTD PMID:18281256 more ... perfluorooctanoic acid multiple interactions ISO RGD:3371 6480464 perfluorooctanoic acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 perfluorooctanoic acid multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA] more ... CTD PMID:16731579 more ... perfluoroundecanoic acid multiple interactions ISO RGD:69168 6480464 perfluoroundecanoic acid binds to and affects the folding of PPARG protein CTD PMID:24998974 permethrin increases expression EXP 6480464 Permethrin results in increased expression of PPARG mRNA, Permethrin results in increased expression of PPARG protein CTD PMID:24911977 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 phenethyl caffeate decreases expression EXP 6480464 caffeic acid phenethyl ester results in decreased expression of PPARG mRNA CTD PMID:21467634 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPARG mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:3371 6480464 Phenobarbital results in increased expression of PPARG mRNA CTD PMID:24090815 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PPARG mRNA CTD PMID:23091169 phenobarbital affects expression ISO RGD:69168 6480464 Phenobarbital affects the expression of PPARG mRNA CTD PMID:19159669 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PPARG mRNA CTD PMID:19482888 phenol increases expression ISO RGD:69168 6480464 Phenol results in increased expression of PPARG mRNA CTD PMID:17547211 Phenylamil multiple interactions EXP 6480464 [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA more ... CTD PMID:20519739 Phenylamil increases expression EXP 6480464 phenylamil results in increased expression of PPARG mRNA CTD PMID:20519739 Phenylamil affects response to substance EXP 6480464 PPARG protein affects the susceptibility to phenylamil CTD PMID:20519739 phorbol 13-acetate 12-myristate increases activity ISO RGD:69168 6480464 Tetradecanoylphorbol Acetate results in increased activity of PPARG protein CTD PMID:15707588 phorbol 13-acetate 12-myristate increases expression ISO RGD:69168 6480464 Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA, Tetradecanoylphorbol Acetate results in increased expression of PPARG protein CTD PMID:12044893 , PMID:16945329 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69168 6480464 [2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] more ... CTD PMID:16945329 , PMID:21511917 phosphatidylcholine increases expression EXP 6480464 Phosphatidylcholines results in increased expression of PPARG mRNA CTD PMID:23911798 phosphorus atom multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 phthalic acid affects binding ISO RGD:69168 6480464 phthalic acid binds to PPARG protein CTD PMID:23843199 phytanic acid affects binding ISO RGD:69168 6480464 Phytanic Acid binds to PPARG protein CTD PMID:23843199 picoxystrobin multiple interactions ISO RGD:69168 6480464 picoxystrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 pioglitazone affects expression ISO RGD:3371 6480464 pioglitazone affects the expression of PPARG mRNA, pioglitazone affects the expression of PPARG protein CTD PMID:28744220 pioglitazone affects binding ISO RGD:69168 6480464 Pioglitazone binds to PPARG protein CTD PMID:11779144 more ... pioglitazone increases activity ISO RGD:69168 6480464 Pioglitazone results in increased activity of PPARG protein CTD PMID:15273253 more ... pioglitazone increases expression EXP 6480464 pioglitazone results in increased expression of PPARG mRNA CTD PMID:11991651 more ... pioglitazone increases expression ISO RGD:69168 6480464 Pioglitazone results in increased expression of PPARG mRNA more ... CTD PMID:11172467 more ... pioglitazone increases activity ISO RGD:3371 6480464 pioglitazone results in increased activity of PPARG protein CTD PMID:19439812 pioglitazone affects response to substance EXP 6480464 PPARG protein affects the susceptibility to pioglitazone CTD PMID:16007095 pioglitazone multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA] more ... CTD PMID:12055599 more ... pioglitazone affects expression EXP 6480464 pioglitazone affects the expression of PPARG, pioglitazone affects the expression of PPARG mRNA CTD PMID:19048458 , PMID:21962020 pioglitazone multiple interactions EXP 6480464 [ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein] more ... CTD PMID:11991651 more ... pioglitazone multiple interactions ISO RGD:69168 6480464 [Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein more ... CTD PMID:11779144 more ... pirinixic acid multiple interactions ISO RGD:69168 6480464 N-2-cyclohexyloxy-4-nitrophenylmethanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA] more ... CTD PMID:11840453 more ... pirinixic acid increases activity ISO RGD:69168 6480464 pirinixic acid results in increased activity of PPARG protein CTD PMID:16386710 , PMID:26135921 pirinixic acid increases expression ISO RGD:3371 6480464 pirinixic acid results in increased expression of PPARG mRNA CTD PMID:22539621 pirinixic acid increases activity EXP 6480464 pirinixic acid results in increased activity of PPARG protein CTD PMID:12401884 , PMID:9703482 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid results in increased activity of PPARG protein] which results in increased expression of NFKBIA mRNA more ... CTD PMID:19438714 , PMID:8700121 pirinixic acid increases expression ISO RGD:69168 6480464 pirinixic acid results in increased expression of PPARG mRNA CTD PMID:11840453 platycodin D decreases expression EXP 6480464 platycodin D results in decreased expression of PPARG mRNA, platycodin D results in decreased expression of PPARG protein CTD PMID:20024897 more ... platycodin D decreases expression ISO RGD:69168 6480464 platycodin D results in decreased expression of PPARG protein CTD PMID:30599906 platycodin D decreases activity EXP 6480464 platycodin D results in decreased activity of PPARG protein CTD PMID:20024897 platycodin D multiple interactions EXP 6480464 CTNNB1 affects the reaction [platycodin D results in increased expression of PPARG mRNA] more ... CTD PMID:20024897 , PMID:21798269 Pomiferin decreases expression ISO RGD:69168 6480464 pomiferin results in decreased expression of PPARG mRNA CTD PMID:20706672 potassium chromate multiple interactions EXP 6480464 potassium chromateVI inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein] CTD PMID:24576443 prallethrin increases expression ISO RGD:69168 6480464 d, d-T80-prallethrin results in increased expression of PPARG mRNA CTD PMID:32473317 Pranoprofen increases activity ISO RGD:69168 6480464 pyranoprofen results in increased activity of PPARG protein CTD PMID:12065695 pravastatin multiple interactions ISO RGD:69168 6480464 Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol] CTD PMID:12044893 prochloraz decreases expression ISO RGD:69168 6480464 prochloraz results in decreased expression of PPARG mRNA CTD PMID:30879083 progesterone increases expression ISO RGD:3371 6480464 Progesterone results in increased expression of PPARG mRNA CTD PMID:16954335 propamocarb decreases expression EXP 6480464 propamocarb results in decreased expression of PPARG mRNA CTD PMID:29137890 propylparaben increases expression EXP 6480464 propylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 propylparaben multiple interactions EXP 6480464 PPARG protein promotes the reaction [propylparaben binds to and results in increased activity of PPARG protein] CTD PMID:24155963 propylparaben multiple interactions ISO RGD:69168 6480464 propylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 prostaglandin D2 multiple interactions ISO RGD:69168 6480464 Prostaglandin D2 affects the localization of and results in increased expression of PPARG protein CTD PMID:23943857 prostaglandin D2 affects localization ISO RGD:69168 6480464 Prostaglandin D2 affects the localization of PPARG protein CTD PMID:23220503 prostaglandin F2alpha multiple interactions EXP 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA, [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG protein CTD PMID:21236357 prostaglandin J2 multiple interactions ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein more ... CTD PMID:11343236 more ... prostaglandin J2 increases expression ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA CTD PMID:12595494 , PMID:14512786 prostaglandin J2 increases activity ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein CTD PMID:17030193 prostaglandin J2 multiple interactions ISO RGD:3371 6480464 9-deoxy-delta-9-prostaglandin D2 promotes the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter], [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] CTD PMID:12777391 , PMID:15150131 protein kinase inhibitor multiple interactions EXP 6480464 PD 0325901 inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein], Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein CTD PMID:26670611 psoralen multiple interactions ISO RGD:3371 6480464 Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA] CTD PMID:27350165 puerarin multiple interactions ISO RGD:3371 6480464 puerarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein] CTD PMID:23500774 puerarin decreases expression ISO RGD:69168 6480464 puerarin results in decreased expression of PPARG mRNA CTD PMID:20706672 pyocyanine decreases expression EXP 6480464 Pyocyanine results in decreased expression of PPARG mRNA CTD PMID:31078726 pyridaben multiple interactions ISO RGD:69168 6480464 pyridaben inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 Pyridostigmine bromide multiple interactions EXP 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 quercetin increases expression ISO RGD:69168 6480464 Quercetin results in increased expression of PPARG mRNA, Quercetin results in increased expression of PPARG protein CTD PMID:25765892 quercetin multiple interactions ISO RGD:3371 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of PPARG mRNA more ... CTD PMID:20580672 , PMID:24039778 quercetin multiple interactions EXP 6480464 Quercetin binds to and results in increased activity of PPARG protein more ... CTD PMID:18262572 more ... quercetin multiple interactions ISO RGD:69168 6480464 Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein], Quercetin promotes the reaction [rosiglitazone results in increased expression of PPARG protein] CTD PMID:18393431 , PMID:25765892 quinoline multiple interactions ISO RGD:69168 6480464 quinoline analog binds to and affects the activity of PPARG protein CTD PMID:17610302 quinolinic acid decreases expression ISO RGD:3371 6480464 Quinolinic Acid results in decreased expression of PPARG mRNA CTD PMID:30130594 quinolinic acid multiple interactions ISO RGD:3371 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA] more ... CTD PMID:30130594 quinoxyfen increases expression ISO RGD:69168 6480464 quinoxyfen results in increased expression of PPARG mRNA CTD PMID:32473317 quizalofop-ethyl increases activity ISO RGD:69168 6480464 quizalofop-ethyl results in increased activity of PPARG protein CTD PMID:31086981 reactive oxygen species multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:16945329 more ... reactive oxygen species multiple interactions EXP 6480464 [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein, Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein] CTD PMID:22046279 rebaudioside A multiple interactions EXP 6480464 rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 resmethrin increases activity ISO RGD:69168 6480464 resmethrin results in increased activity of PPARG protein CTD PMID:20143881 resveratrol multiple interactions EXP 6480464 [Resveratrol co-treated with Dietary Fats] results in decreased expression of PPARG mRNA more ... CTD PMID:18555852 more ... resveratrol multiple interactions ISO RGD:3371 6480464 Resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:18793633 more ... resveratrol affects activity EXP 6480464 resveratrol affects the activity of PPARG protein CTD PMID:23525482 resveratrol affects response to substance EXP 6480464 PPARG protein affects the susceptibility to resveratrol CTD PMID:23525482 resveratrol decreases expression ISO RGD:69168 6480464 resveratrol results in decreased expression of PPARG mRNA, resveratrol results in decreased expression of PPARG protein CTD PMID:20706672 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of PPARG protein CTD PMID:24036142 resveratrol decreases expression ISO RGD:3371 6480464 resveratrol results in decreased expression of PPARG mRNA CTD PMID:23848300 resveratrol increases expression ISO RGD:69168 6480464 resveratrol analog results in increased expression of PPARG mRNA more ... CTD PMID:20372816 more ... resveratrol multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol results in increased expression of PPARG mRNA] more ... CTD PMID:18776171 more ... resveratrol increases activity ISO RGD:69168 6480464 resveratrol results in increased activity of PPARG protein CTD PMID:16849586 more ... resveratrol decreases expression EXP 6480464 resveratrol analog results in decreased expression of PPARG mRNA more ... CTD PMID:16813520 more ... retinyl acetate multiple interactions EXP 6480464 [retinol acetate co-treated with 2 more ... CTD PMID:31449830 riddelliine decreases expression ISO RGD:3371 6480464 riddelliine results in decreased expression of PPARG mRNA CTD PMID:18047727 rifampicin increases expression EXP 6480464 Rifampin results in increased expression of PPARG mRNA CTD PMID:27806127 rifampicin multiple interactions EXP 6480464 Rifampin results in increased expression of and affects the localization of PPARG protein CTD PMID:27806127 rifaximin multiple interactions ISO RGD:69168 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of PPARG mRNA CTD PMID:22790967 rimonabant affects expression EXP 6480464 Rimonabant affects the expression of PPARG mRNA CTD PMID:20110567 risperidone increases expression EXP 6480464 Risperidone results in increased expression of PPARG mRNA, Risperidone results in increased expression of PPARG protein CTD PMID:20564506 risperidone multiple interactions EXP 6480464 Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA], Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein] CTD PMID:20564506 ritonavir multiple interactions EXP 6480464 Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein] CTD PMID:11101056 ritonavir increases expression ISO RGD:69168 6480464 Ritonavir results in increased expression of PPARG mRNA CTD PMID:17879945 Ro 41-5253 multiple interactions EXP 6480464 [Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein, Ro 41-5253 results in increased activity of and results in decreased expression of PPARG protein CTD PMID:17290005 Ro 41-5253 multiple interactions ISO RGD:69168 6480464 [Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein more ... CTD PMID:17290005 Rosavin decreases expression ISO RGD:69168 6480464 rosavin results in decreased expression of PPARG mRNA CTD PMID:20706672 rosmarinic acid multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA] more ... CTD PMID:28744220 rosmarinic acid affects expression ISO RGD:3371 6480464 rosmarinic acid affects the expression of PPARG mRNA, rosmarinic acid affects the expression of PPARG protein CTD PMID:28744220 rotenone decreases expression ISO RGD:3371 6480464 Rotenone results in decreased expression of PPARG mRNA, Rotenone results in decreased expression of PPARG protein CTD PMID:19693701 rotenone multiple interactions ISO RGD:69168 6480464 [Rosiglitazone co-treated with Rotenone] results in increased expression of PPARG protein, Rotenone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:24374061 , PMID:30818834 rottlerin multiple interactions ISO RGD:69168 6480464 rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] CTD PMID:17030193 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]], S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA] CTD PMID:21520053 , PMID:27358406 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of PPARG mRNA CTD PMID:21520053 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:3371 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA] more ... CTD PMID:17602960 salicylic acid multiple interactions ISO RGD:3371 6480464 Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 Salmeterol xinafoate multiple interactions ISO RGD:69168 6480464 Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] CTD PMID:15531761 SB 203580 multiple interactions EXP 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] CTD PMID:14984747 SB 203580 multiple interactions ISO RGD:3371 6480464 SB 203580 inhibits the reaction [Ethanol results in decreased expression of PPARG protein] CTD PMID:24412557 SB 203580 increases expression ISO RGD:3371 6480464 SB 203580 results in increased expression of PPARG mRNA, SB 203580 results in increased expression of PPARG protein CTD PMID:24412557 SB 203580 decreases expression EXP 6480464 SB 203580 results in decreased expression of PPARG mRNA, SB 203580 results in decreased expression of PPARG protein CTD PMID:23603106 SB 431542 multiple interactions ISO RGD:69168 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of PPARG mRNA CTD PMID:27188386 selenic acid increases expression EXP 6480464 Selenic Acid results in increased expression of PPARG mRNA CTD PMID:16443359 selenium atom multiple interactions EXP 6480464 PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide more ... CTD PMID:17439952 serotonin increases localization ISO RGD:69168 6480464 Serotonin results in increased localization of PPARG protein CTD PMID:25766885 serotonin multiple interactions ISO RGD:69168 6480464 [Serotonin results in increased localization of and results in increased activity of PPARG protein] which results in increased expression of AQP3 mRNA, Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein] CTD PMID:25766885 sildenafil citrate multiple interactions EXP 6480464 8-4-chlorophenylthioguanosine 3', 5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein] CTD PMID:20471953 sildenafil citrate increases expression EXP 6480464 Sildenafil Citrate results in increased expression of PPARG mRNA, Sildenafil Citrate results in increased expression of PPARG protein CTD PMID:20471953 silibinin multiple interactions EXP 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] CTD PMID:25559859 silibinin increases expression ISO RGD:69168 6480464 Silybin results in increased expression of PPARG protein CTD PMID:27746612 silicon dioxide increases expression ISO RGD:69168 6480464 Silicon Dioxide analog results in increased expression of PPARG mRNA CTD PMID:25895662 simvastatin multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA], [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 protein] CTD PMID:15781755 simvastatin decreases expression ISO RGD:3371 6480464 Simvastatin results in decreased expression of PPARG CTD PMID:19216230 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol more ... CTD PMID:20835264 sirolimus affects expression ISO RGD:69168 6480464 Sirolimus affects the expression of PPARG protein CTD PMID:17016853 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of PPARG mRNA CTD PMID:15358118 sirolimus multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein, [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein CTD PMID:17016853 sodium arsenate decreases expression EXP 6480464 sodium arsenate analog results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenate decreases expression ISO RGD:69168 6480464 sodium arsenate analog results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenite decreases expression ISO RGD:69168 6480464 sodium arsenite results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenite increases expression ISO RGD:3371 6480464 sodium arsenite results in increased expression of PPARG protein CTD PMID:28283887 sodium arsenite decreases expression ISO RGD:3371 6480464 sodium arsenite results in decreased expression of PPARG protein CTD PMID:30551535 sodium arsenite multiple interactions ISO RGD:3371 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 more ... sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PPARG mRNA, sodium arsenite results in increased expression of PPARG protein CTD PMID:25367288 more ... sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PPARG mRNA, sodium arsenite results in decreased expression of PPARG protein CTD PMID:21396911 more ... sodium arsenite multiple interactions EXP 6480464 gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA] more ... CTD PMID:11812925 more ... sodium atom affects abundance EXP 6480464 PPARG protein affects the abundance of Sodium CTD PMID:16007095 splitomicin multiple interactions EXP 6480464 splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG mRNA], splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG protein] CTD PMID:23525482 stavudine decreases expression ISO RGD:69168 6480464 Stavudine results in decreased expression of PPARG mRNA CTD PMID:14518702 stavudine decreases expression EXP 6480464 Stavudine results in decreased expression of PPARG mRNA, Stavudine results in decreased expression of PPARG protein CTD PMID:15722030 , PMID:17926646 stearoyl-CoA multiple interactions ISO RGD:69168 6480464 stearoyl-coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 steviol multiple interactions EXP 6480464 steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 stevioside multiple interactions EXP 6480464 stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 stilben-4-ol decreases expression EXP 6480464 4-hydroxystilbene results in decreased expression of PPARG mRNA CTD PMID:23748787 streptozocin decreases expression ISO RGD:3371 6480464 Streptozocin results in decreased expression of PPARG more ... CTD PMID:12967931 more ... streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of PPARG mRNA CTD PMID:23319174 streptozocin increases expression ISO RGD:3371 6480464 Streptozocin results in increased expression of PPARG mRNA, Streptozocin results in increased expression of PPARG protein CTD PMID:20219977 , PMID:21450970 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of PPARG mRNA, Streptozocin results in decreased expression of PPARG protein CTD PMID:21381899 , PMID:30642005 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA more ... CTD PMID:21381899 more ... streptozocin multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:12967931 more ... succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA CTD PMID:26378955 sucrose multiple interactions EXP 6480464 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA, Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA] CTD PMID:24440342 sulfasalazine increases expression ISO RGD:3371 6480464 Sulfasalazine results in increased expression of PPARG mRNA CTD PMID:19365232 sulfasalazine multiple interactions ISO RGD:3371 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA], Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein] CTD PMID:26165751 sulfasalazine increases expression EXP 6480464 Sulfasalazine results in increased expression of PPARG mRNA CTD PMID:31830553 sulforaphane increases expression ISO RGD:69168 6480464 sulforafan results in increased expression of PPARG mRNA CTD PMID:26833863 sulfur dioxide multiple interactions EXP 6480464 glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein] more ... CTD PMID:26209559 sulfur dioxide decreases expression EXP 6480464 Sulfur Dioxide results in decreased expression of PPARG protein CTD PMID:26209559 sulindac sulfide multiple interactions ISO RGD:69168 6480464 [sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein more ... CTD PMID:10866999 more ... sulindac sulfide increases expression ISO RGD:69168 6480464 sulindac sulfide results in increased expression of PPARG mRNA CTD PMID:11948457 sulindac sulfide increases activity ISO RGD:69168 6480464 sulindac sulfide results in increased activity of PPARG protein CTD PMID:10866999 sulindac sulfide affects binding ISO RGD:69168 6480464 sulindac sulfide analog binds to PPARG protein CTD PMID:18665581 sulindac sulfone multiple interactions ISO RGD:69168 6480464 [sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer], PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA] CTD PMID:14506281 sulindac sulfone increases expression ISO RGD:69168 6480464 sulindac sulfone results in increased expression of PPARG mRNA CTD PMID:11948457 sunitinib decreases expression ISO RGD:69168 6480464 Sunitinib results in decreased expression of PPARG mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:3371 6480464 T-2 Toxin results in increased expression of PPARG mRNA CTD PMID:26141394 tacrolimus hydrate multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein CTD PMID:17016853 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of PPARG mRNA CTD PMID:25123088 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of PPARG protein CTD PMID:27358406 tamoxifen multiple interactions EXP 6480464 PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]] more ... CTD PMID:27358406 tamoxifen multiple interactions ISO RGD:69168 6480464 Tamoxifen inhibits the reaction [PPARG protein binds to CD36 promoter] more ... CTD PMID:27358406 Tanshinone I decreases expression EXP 6480464 tanshinone results in decreased expression of PPARG mRNA CTD PMID:20854809 taurine multiple interactions ISO RGD:3371 6480464 Taurine inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein] CTD PMID:30551535 taurine multiple interactions ISO RGD:69168 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein] CTD PMID:30362509 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein] CTD PMID:30362509 tebufenpyrad increases activity ISO RGD:69168 6480464 4-chloro-N-4-1, 1-dimethylethylphenylmethyl-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased activity of PPARG protein CTD PMID:20143881 telmisartan multiple interactions ISO RGD:69168 6480464 PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]] more ... CTD PMID:18158351 , PMID:22124178 telmisartan multiple interactions ISO RGD:3371 6480464 telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA], telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] CTD PMID:20888384 , PMID:24831514 telmisartan increases expression EXP 6480464 telmisartan results in increased expression of PPARG protein CTD PMID:20176998 telmisartan multiple interactions EXP 6480464 telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:21381899 telmisartan increases activity ISO RGD:69168 6480464 Telmisartan results in increased activity of PPARG protein CTD PMID:22124178 , PMID:28728110 tenofovir disoproxil fumarate affects expression ISO RGD:69168 6480464 Tenofovir affects the expression of PPARG mRNA CTD PMID:20032539 tert-butyl ethyl ether increases expression ISO RGD:3371 6480464 ethyl tert-butyl ether results in increased expression of PPARG mRNA CTD PMID:24090815 tert-butyl hydroperoxide multiple interactions ISO RGD:69168 6480464 tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter] more ... CTD PMID:20847119 tert-butyl hydroperoxide increases activity ISO RGD:69168 6480464 tert-Butylhydroperoxide results in increased activity of PPARG protein CTD PMID:16417216 Tesaglitazar multiple interactions ISO RGD:69168 6480464 tesaglitazar binds to and results in increased activity of PPARG protein CTD PMID:17610302 Tesaglitazar affects expression ISO RGD:3371 6480464 tesaglitazar affects the expression of PPARG mRNA CTD PMID:21270424 Tesaglitazar increases activity EXP 6480464 tesaglitazar results in increased activity of PPARG protein CTD PMID:12401884 Tesaglitazar increases activity ISO RGD:69168 6480464 tesaglitazar results in increased activity of PPARG protein CTD PMID:12401884 testosterone decreases expression ISO RGD:69168 6480464 Testosterone results in decreased expression of PPARG mRNA CTD PMID:21632903 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of PPARG mRNA, Testosterone results in decreased expression of PPARG protein CTD PMID:12960001 , PMID:20844152 Tetrachlorobisphenol A increases activity ISO RGD:69168 6480464 tetrachlorodian analog results in increased activity of PPARG protein, tetrachlorodian results in increased activity of PPARG protein CTD PMID:24591153 more ... Tetrachlorobisphenol A affects binding ISO RGD:69168 6480464 tetrachlorodian binds to PPARG protein CTD PMID:25314719 Tetrachlorobisphenol A multiple interactions ISO RGD:69168 6480464 tetrachlorodian binds to and results in increased activity of PPARG protein more ... CTD PMID:21561829 more ... tetrachloromethane multiple interactions ISO RGD:3371 6480464 4-5-4-chlorophenyl-3-trifluoromethyl-1H-pyrazol-1-ylbenzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] more ... CTD PMID:12055599 more ... tetrachloromethane increases expression ISO RGD:3371 6480464 Carbon Tetrachloride results in increased expression of PPARG mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PPARG mRNA, Carbon Tetrachloride results in decreased expression of PPARG protein CTD PMID:28428136 tetrachloromethane multiple interactions EXP 6480464 [Ethanol co-treated with Carbon Tetrachloride co-treated with 4-O-methylhonokiol] results in decreased expression of PPARG mRNA more ... CTD PMID:28428136 , PMID:28689299 tetrachloromethane decreases activity ISO RGD:3371 6480464 Carbon Tetrachloride results in decreased activity of PPARG protein CTD PMID:25858767 tetrachloromethane decreases expression ISO RGD:3371 6480464 Carbon Tetrachloride results in decreased expression of PPARG mRNA, Carbon Tetrachloride results in decreased expression of PPARG protein CTD PMID:12055599 more ... tetrachloromethane affects expression ISO RGD:3371 6480464 Carbon Tetrachloride affects the expression of PPARG protein CTD PMID:15959796 tetramethylpyrazine increases expression ISO RGD:3371 6480464 tetramethylpyrazine results in increased expression of PPARG protein CTD PMID:23022513 tetramethylpyrazine increases expression ISO RGD:69168 6480464 tetramethylpyrazine results in increased expression of PPARG mRNA CTD PMID:28034800 tetramethylpyrazine multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] CTD PMID:22200888 theophylline increases expression ISO RGD:69168 6480464 Theophylline results in increased expression of PPARG mRNA, Theophylline results in increased expression of PPARG protein CTD PMID:16569937 thiamine(1+) chloride increases activity ISO RGD:3371 6480464 Thiamine results in increased activity of PPARG protein CTD PMID:31419397 thiamine(1+) chloride multiple interactions ISO RGD:3371 6480464 Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 thiazolidinediones multiple interactions ISO RGD:3371 6480464 [Thiazolidinediones binds to and results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides, Thiazolidinediones binds to and results in increased activity of PPARG protein CTD PMID:19248225 thiazolidinediones multiple interactions ISO RGD:69168 6480464 PPARG protein promotes the reaction [Thiazolidinediones results in increased abundance of Lipids] CTD PMID:20079722 thiazolidinediones increases expression EXP 6480464 Thiazolidinediones results in increased expression of PPARG mRNA CTD PMID:21870829 thioacetamide increases expression ISO RGD:3371 6480464 Thioacetamide results in increased expression of PPARG mRNA CTD PMID:23411599 thymoquinone multiple interactions ISO RGD:69168 6480464 PRKAA1 protein promotes the reaction [thymoquinone results in increased expression of PPARG protein], thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] CTD PMID:27688165 thymoquinone increases expression ISO RGD:69168 6480464 thymoquinone results in increased expression of PPARG protein CTD PMID:27688165 thyroxine multiple interactions EXP 6480464 Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein] CTD PMID:28973666 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of PPARG mRNA, titanium dioxide results in decreased expression of PPARG protein CTD PMID:23557971 , PMID:28646487 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA CTD PMID:29950665 toluene 2,4-diisocyanate multiple interactions EXP 6480464 pioglitazone promotes the reaction [Toluene 2 more ... CTD PMID:17015710 toluene 2,4-diisocyanate increases localization EXP 6480464 Toluene 2, 4-Diisocyanate results in increased localization of PPARG protein CTD PMID:17015710 tomelukast multiple interactions EXP 6480464 LY 171883 results in increased activity of [PPARG protein co-treated with RXRA protein] CTD PMID:8700121 topotecan affects expression ISO RGD:3371 6480464 Topotecan affects the expression of PPARG mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:3371 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:69168 6480464 torcetrapib results in increased expression of PPARG mRNA CTD PMID:25617244 torcetrapib multiple interactions ISO RGD:69168 6480464 2-acetylphenothiazine inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA], setanaxib inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA] CTD PMID:25617244 trans-caffeic acid increases expression EXP 6480464 caffeic acid results in increased expression of PPARG mRNA CTD PMID:21870829 trans-chalcone increases expression EXP 6480464 Chalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 trans-cinnamic acid increases expression EXP 6480464 cinnamic acid results in increased expression of PPARG mRNA CTD PMID:21870829 tributyl phosphate affects binding ISO RGD:69168 6480464 tributyl phosphate binds to PPARG protein CTD PMID:25314719 , PMID:30966736 tributyl phosphate increases activity ISO RGD:69168 6480464 tributyl phosphate results in increased activity of PPARG protein CTD PMID:26172262 , PMID:28282128 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of PPARG mRNA, tributyltin results in increased expression of PPARG protein CTD PMID:21622945 more ... tributylstannane multiple interactions ISO RGD:3371 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein CTD PMID:31129395 tributylstannane increases expression ISO RGD:69168 6480464 tributyltin results in increased expression of PPARG mRNA CTD PMID:26961604 , PMID:29787037 tributylstannane increases expression ISO RGD:3371 6480464 tributyltin results in increased expression of PPARG protein CTD PMID:25819109 more ... tributylstannane affects binding ISO RGD:69168 6480464 tributyltin binds to PPARG protein CTD PMID:25314719 , PMID:32407875 tributylstannane increases activity EXP 6480464 tributyltin results in increased activity of PPARG protein CTD PMID:25777084 tributylstannane multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of PPARG mRNA] more ... CTD PMID:19497422 more ... tributylstannane multiple interactions EXP 6480464 PPARG protein promotes the reaction [tributyltin binds to and results in increased activity of PPARG protein] more ... CTD PMID:22197818 more ... tributylstannane increases activity ISO RGD:69168 6480464 tributyltin results in increased activity of PPARG protein CTD PMID:21622945 more ... Tributyltin oxide increases expression EXP 6480464 bistri-n-butyltinoxide results in increased expression of PPARG mRNA CTD PMID:18958704 trichloroethene multiple interactions EXP 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of PPARG mRNA] CTD PMID:20709644 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PPARG mRNA CTD PMID:20709644 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of PPARG mRNA, Triclosan results in decreased expression of PPARG protein CTD PMID:15707987 , PMID:28973666 triclosan increases expression ISO RGD:69168 6480464 Triclosan results in increased expression of PPARG mRNA CTD PMID:30510588 triclosan affects expression ISO RGD:69168 6480464 Triclosan affects the expression of PPARG mRNA CTD PMID:31714634 triclosan multiple interactions EXP 6480464 [rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [Triclosan results in decreased phosphorylation of AKT1 protein], Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein] CTD PMID:28973666 triclosan affects binding ISO RGD:69168 6480464 Triclosan binds to PPARG protein CTD PMID:25314719 triflumizole increases activity EXP 6480464 triflumizol results in increased activity of PPARG protein CTD PMID:23086663 triflumizole increases expression EXP 6480464 triflumizol results in increased expression of PPARG mRNA CTD PMID:23086663 triflumizole increases activity ISO RGD:69168 6480464 triflumizol results in increased activity of PPARG protein CTD PMID:20143881 triphenyl phosphate multiple interactions EXP 6480464 [tris1 more ... CTD PMID:29112739 , PMID:32360330 triphenyl phosphate increases activity ISO RGD:69168 6480464 triphenyl phosphate results in increased activity of PPARG protein CTD PMID:26172262 more ... triphenyl phosphate multiple interactions ISO RGD:69168 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PPARG mRNA more ... CTD PMID:28282128 more ... triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PPARG mRNA CTD PMID:28163246 triphenyl phosphate affects binding ISO RGD:69168 6480464 triphenyl phosphate binds to PPARG protein, triphenyl phosphate metabolite binds to PPARG protein CTD PMID:25062436 , PMID:25314719 triphenyl phosphate increases expression ISO RGD:69168 6480464 triphenyl phosphate results in increased expression of PPARG mRNA CTD PMID:25062436 , PMID:28934090 triphenylstannane multiple interactions ISO RGD:69168 6480464 triphenyltin binds to and results in increased activity of PPARG protein CTD PMID:24786373 triphenylstannane affects binding ISO RGD:69168 6480464 triphenyltin binds to PPARG protein CTD PMID:25314719 , PMID:27725436 triphenylstannane increases activity EXP 6480464 triphenyltin results in increased activity of PPARG protein CTD PMID:25777084 triphenylstannane decreases expression ISO RGD:3371 6480464 triphenyltin results in decreased expression of PPARG mRNA CTD PMID:32504733 tris(2-butoxyethyl) phosphate affects binding ISO RGD:69168 6480464 tris2-butoxyethyl phosphate binds to PPARG protein CTD PMID:25314719 tris(2-chloroethyl) phosphate decreases expression ISO RGD:69168 6480464 trischloroethylphosphate results in decreased expression of PPARG protein CTD PMID:30966736 troglitazone increases response to substance ISO RGD:69168 6480464 PPARG protein results in increased susceptibility to troglitazone CTD PMID:12824901 troglitazone increases activity ISO RGD:69168 6480464 troglitazone results in increased activity of PPARG protein CTD PMID:15345676 more ... troglitazone multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:10871190 more ... troglitazone affects activity ISO RGD:3371 6480464 troglitazone affects the activity of PPARG protein CTD PMID:25596134 troglitazone decreases methylation EXP 6480464 troglitazone results in decreased methylation of PPARG promoter CTD PMID:24559133 troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of PPARG mRNA, Troglitazone results in increased expression of PPARG protein CTD PMID:11113387 more ... troglitazone increases activity EXP 6480464 troglitazone results in increased activity of PPARG protein CTD PMID:11683414 more ... troglitazone increases expression ISO RGD:69168 6480464 Troglitazone results in increased expression of PPARG mRNA more ... CTD PMID:10097144 more ... troglitazone increases expression ISO RGD:3371 6480464 Troglitazone results in increased expression of PPARG mRNA, Troglitazone results in increased expression of PPARG protein CTD PMID:10662598 more ... troglitazone increases activity ISO RGD:3371 6480464 troglitazone results in increased activity of PPARG protein alternative form CTD PMID:15211114 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of PPARG mRNA CTD PMID:12732648 , PMID:16813520 troglitazone increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to troglitazone CTD PMID:15581905 troglitazone increases phosphorylation ISO RGD:69168 6480464 troglitazone results in increased phosphorylation of PPARG protein alternative form CTD PMID:12475986 troglitazone decreases activity ISO RGD:69168 6480464 troglitazone results in decreased activity of PPARG protein alternative form CTD PMID:12475986 troglitazone affects response to substance ISO RGD:69168 6480464 PPARG gene SNP affects the susceptibility to troglitazone CTD PMID:16249460 troglitazone multiple interactions ISO RGD:3371 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] more ... CTD PMID:11318962 more ... troglitazone multiple interactions EXP 6480464 +-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:10871190 more ... troglitazone affects binding ISO RGD:69168 6480464 troglitazone analog binds to PPARG protein, troglitazone binds to PPARG protein CTD PMID:11779144 more ... tungsten multiple interactions EXP 6480464 Tungsten promotes the reaction [rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:26865663 tungsten increases expression EXP 6480464 Tungsten results in increased expression of PPARG mRNA CTD PMID:26865663 tyrphostin AG 1478 multiple interactions ISO RGD:69168 6480464 RTKI cpd inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] CTD PMID:31075703 ursodeoxycholic acid decreases expression ISO RGD:69168 6480464 Ursodeoxycholic Acid results in decreased expression of PPARG mRNA CTD PMID:24312631 ursolic acid multiple interactions ISO RGD:3371 6480464 2 more ... CTD PMID:27274199 valproic acid multiple interactions ISO RGD:69168 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:24489787 , PMID:27188386 valproic acid affects expression ISO RGD:69168 6480464 Valproic Acid affects the expression of PPARG mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:69168 6480464 Valproic Acid results in decreased methylation of PPARG gene CTD PMID:29154799 valproic acid increases expression ISO RGD:69168 6480464 Valproic Acid results in increased expression of PPARG mRNA CTD PMID:24383497 , PMID:28001369 valsartan decreases expression ISO RGD:69168 6480464 Valsartan results in decreased expression of PPARG mRNA CTD PMID:22768174 vitamin D affects expression ISO RGD:69168 6480464 Vitamin D affects the expression of PPARG mRNA CTD PMID:20368581 vitamin E multiple interactions ISO RGD:3371 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 vitamin E increases expression ISO RGD:3371 6480464 alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:11752099 vitamin E increases expression ISO RGD:69168 6480464 alpha-Tocopherol results in increased expression of PPARG mRNA, alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 , PMID:28062356 vitamin E increases activity ISO RGD:69168 6480464 alpha-Tocopherol results in increased activity of PPARG protein CTD PMID:19083475 wogonin multiple interactions ISO RGD:3371 6480464 wogonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein] CTD PMID:31103702 wortmannin multiple interactions ISO RGD:3371 6480464 wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA] CTD PMID:23399309 Y-27632 increases expression ISO RGD:3371 6480464 Y 27632 results in increased expression of PPARG mRNA CTD PMID:20578043 zearalenone decreases activity ISO RGD:69168 6480464 Zearalenone results in decreased activity of PPARG protein CTD PMID:27481073 zearalenone increases expression ISO RGD:69168 6480464 Zearalenone results in increased expression of PPARG mRNA, Zearalenone results in increased expression of PPARG protein CTD PMID:32119988 zearalenone decreases methylation ISO RGD:69168 6480464 Zearalenone results in decreased methylation of PPARG promoter CTD PMID:32119988 zidovudine decreases expression EXP 6480464 Zidovudine results in decreased expression of PPARG mRNA, Zidovudine results in decreased expression of PPARG protein CTD PMID:15722030 , PMID:17926646 zinc atom multiple interactions ISO RGD:69168 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA CTD PMID:18593933 zinc atom multiple interactions EXP 6480464 [LDLR gene mutant form results in increased susceptibility to Zinc deficiency] which results in increased expression of PPARG mRNA CTD PMID:16140885 zinc atom decreases expression ISO RGD:3371 6480464 Zinc deficiency results in decreased expression of PPARG mRNA CTD PMID:20128680 zinc protoporphyrin multiple interactions ISO RGD:69168 6480464 zinc protoporphyrin inhibits the reaction [cilostazol results in increased activity of PPARG protein], zinc protoporphyrin inhibits the reaction [rosiglitazone results in increased activity of PPARG protein] CTD PMID:21660147 zinc(0) multiple interactions ISO RGD:69168 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA CTD PMID:18593933 zinc(0) decreases expression ISO RGD:3371 6480464 Zinc deficiency results in decreased expression of PPARG mRNA CTD PMID:20128680 zinc(0) multiple interactions EXP 6480464 [LDLR gene mutant form results in increased susceptibility to Zinc deficiency] which results in increased expression of PPARG mRNA CTD PMID:16140885 ziram affects expression ISO RGD:69168 6480464 Ziram affects the expression of PPARG mRNA CTD PMID:32712770 zoledronic acid affects activity ISO RGD:69168 6480464 zoledronic acid affects the activity of PPARG protein CTD PMID:25596134
